Philippine National Formulary - Essential Medicines List
In this document:
- •●
- •(1)
- •Use with extreme caution in doses exceeding 30 mg per day; contraindicated in acute coronaryevents
- •Specific expertise, diagnostic precision, orspecial equipment required for proper use (2)
~15k words
Document Info
Philippine National Formulary - Essential Medicines List
Philippine National Formulary
Essential Medicines List (as of November 02, 2022)
For new updates, you may download the latest version (PDF copy) at www.pharmadiv.gov.ph
Volume I, 8th Edition (2019)
Published by:
Pharmaceutical Division – Health Regulation Team DEPARTMENT OF HEALTH Manila, Philippines
PHILIPPINE NATIONAL FORMULARY ESSENTIAL MEDICINES LIST 8th Edition 2017
DEPARTMENT OF HEALTH
Francisco T. Duque III, MD, MSc Secretary of Health
Rolando Enrique D. Domingo, MD, DPBO Undersecretary of Health Health Regulation Team
Lyndon L. Lee Suy, MD, MPH Assistant Secretary of Health Health Regulation Team
FORMULARY EXECUTIVE COUNCIL Froilan A. Bagabaldo, RPh, LlB (Chair) Cleotilde H. How, MD, FPSECP, FPPS Cecilia A. Jimeno, MD, FPCP, FPSEDM Cecilia C. Maramba-Lazarte, MD, MScID, MSCCT, FPPS, FPIDSP, FPSECP Paul Matthew D. Pasco, MD, MSc, FPNA Imelda G. Peña, RPh, MS, DrPH John Q. Wong, MD, MSc
PHILIPPINE NATIONAL FORMULARY ESSENTIAL MEDICINES LIST 8th Edition 2017
PHILIPPINE NATIONAL FORMULARY SECRETARIAT
Anna Melissa S. Guerrero, MD, MPH, (HTA) Chief Pharmaceutical Division
Irene V. Florentino-Fariñas, RPh, MD, MNSA Medical Officer IV Pharmaceutical Division
Joyce Anne dP. Ceria-Pereña, RPh, MPM Pharmacist V
Johanna B. Mallari, RPh Pharmacist III
Anna Patricia D. Tiosejo, RPh Pharmacist II
John Michael L. Roque Technical Assistant
Republic of the Philippines Department of Health OFFICE OF THE SECRETARY
MESSAGE
The revitalization of the Fourmula One Plus for Health as the framework of the healthcare reform agenda of the national government is anchored on the values of equitable and inclusive health system, transparent and accountable provision of quality health services, and efficient use of resources. The 8th edition of the Philippine National Formulary (PNF) Essential Medicines List (EML) is a tool to exercise these values while contributing to the achievement of the objectives of financial protection and better health outcomes. As an essential medicines list, its previous editions have been the basis of tailored procurement of medicines in public health facilities while providing efficient use of limited resources. It is also the basis of the Philippine Health Insurance Corporation (PhilHealth) in reimbursing claims to end-usersfor medicines use. With its new format and content, the PNF EML 8th edition can now maximize the PNF’s contribution to the rational use of medicines. Its abridged content is intended to provide concise evidence-based drug information which is vital in medical practice. The latest PNF EML is a useful tool to ensure rational prescribing, dispensing and administration of medicines. I would like to encourage our health professionals to fully utilize it in their medicines procurement as well as in their day-to-day clinical decision-making. Let us continue to work for our shared vision of all for health towards health for all!
Mabuhay!
FRANCISCO T. DUQUE III, MD, MSc Secretary of Health
Republic of the Philippines Department of Health OFFICE OF THE SECRETARY
21 luly 2016
DEPARTMENT MEMORANDUM No.2016- 0258
FOR: ALL DIRECTORS OF BUREAUS AND REGIONAL OFFICES, SECRETARY OF HEALTH DOH-ARMM; CHIEFS OF MEDICAL CENTERS, HOSPITALS AND SANITARIA; AND OTHERSCONCERNED
SUBJECT: Further clarification and guidance on the bidding specifications of solid oral dosage forms (tablets) in the Philippine National Formularv (PNF)
This is to inform everyone that, as per clarification and recommendation of the Food and Drug Administration (FDA), the bidding of TABLET shall be open to both uncoated and coated (film- and sugar-coated) tablets, unless otherwise specified in the PNF.
On the other hand, for thebiddingof the following solid oraldosage forms, the specific type of tablet should be clearly reflected in thepurchaserequest:
- film-coatedtablets:
- soluble tablets;
- dispersible tablets;
- effervescent tablets;
- chewable tablets:
- tablets for use in the mouth (including orally disintegrating, sublingual and buccal tablets): and
- modified-release tablets (including delayed-release tablets gastro-resistant/enteric-coated tablets) and sustained-release tablets (extended-/prolonged-release tablets)).
For urgent and strict implementation.
PAULYN JEAN B. ROSELL-UBIAL, MD, MPH, CESO II Secretary of Health
ABBREVIATIONS AND SYSTEM OF MEASUREMENTS
●
Medicinal plant product registered with BFAD
(1)
Use with extreme caution in doses exceeding 30 mg per day; contraindicated in acute coronaryevents
Specific expertise, diagnostic precision, orspecial equipment required for proper use (2)
Limited indications or narrow spectrum of activity (A1)
Dangerous Drug Preparations to be prescribed and dispensed through the DOH Official Prescription Form (Yellow Rx). Only one (1) dangerous drug preparation shall be prescribed in one single prescription form. Partial filling allowed. STRICTLY NO REFILL. ⊗
- To be prescribed using Personalized Prescription issued by the prescribing physician with the S2 license # indicated therein. Only one (1) drug preparation shall be prescribed in one single prescription form. Partial filling allowed. STRICTLY NO REFILL. (A2)
-
Drug Preparations Containing Controlled Chemicals
to be dispensed and prescribed through a Personalized Prescription issued by a prescribing physician with the S2 license #, among others, indicated therein. Only one (1) drug preparation shall be prescribed in one single prescription form. Partial filling allowed. STRICTLY NOREFILL. List B medicines requiring in vivo bioequivalence studies DPI
Dry Powder Inhaler equiv.
equivalent EU
ELISA Unit g
Gram (ID)
Intradermal Injection (IM)
Intramuscular Injection Inj.
Injection IU
International Unit/s (IV)
Intravenous Injection L
Liter mcg
Microgram mCi
Millicurie B
MDI
Metered Dose Inhaler mEq
Milliequivalent mg
Milligram mL
Milliliter Modified Release (includes Controlled Release (CR), MR
Extended Release (ER) Sustained Release (SR), Long Acting (LA), etc.) NSAID
Non-Steroidal Anti-Inflammatory Drug pen. G
Penicillin G PFU
Plaque Forming Unit RE
Retinol Equivalent Resp. Soln.
Respiratory Solution S2
- License required for prescription of Dangerous Drugs Preparations and Controlled Chemicals by the Physicians / Dentists / Veterinarians (SC)
Subcutaneous Injection
Soln.
Solution
MEASUREMENTS:
1 grain
60 mg ½ grain
30 mg Quantities of 1 gram or more should be written as 1 g, etc.
Quantities of less than 1 gram should be written in milligrams, e.g., 500 mg, not 0.5 g. Quantities less than 1 milligram should be written in microgram/s, e.g., 100 microgram/s not 0.1 mg. When decimals are unavoidable, a zero should be written before the decimal point where there is no figure, e.g., 0.5 mL, not .5 mL.
The term milliliter (mL) should be used and not cubic centimeters or cc or m3.
1
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
A
Abacavir
Oral: 300mg tablet (as sulfate)
Acetated Ringer’s Solution
Inj.: 500 mL and 1 L bottle/bag (IV infusion)
Composition:
Na+ — 130 mmol/L
K+ — 4 mmol/L
Ca++ — 3 mmol/L
Cl‐ — 109 mmol/L
Acetazolamide (B)
Oral: 250 mg tablet
Acetylcysteine
Oral: 600 mg effervescent tablet
100 mg and 200 mg sachet
100 mg/5 mL granules for suspension, 150 mL
Inj.: 200 mg/mL, 10 mL ampul (IV infusion) (1, 2)
200 mg/mL, 25 mL bottle (IV infusion)
Inhalation:
100 mg/mL, 3 mL ampule solution for inhalation
Aciclovir
Oral: 200 mg, 400 mg and 800 mg tablet
200 mg/5 mL suspension, 60 mL and 120mL
Inj.: 25 mg/mL, 10 mL vial (IV infusion)
Activated Charcoal
Oral: powder, USP grade given as slurry
Adenosine (1, 2)
Inj.: 3 mg/mL, 2 mL vial (IV)
Adrenaline (see Epinephrine)
Albendazole
Oral: 400 mg chewable tablet (B)
200 mg/5 mL suspension, 10 mL and 60 mL
Albumin, Human (1, 2)
Inj.: 20%, 50 mL and 100 mL bottle (IV, IV infusion)
25%, 50 mL and 100 mL bottle (IV, IV infusion)
25%, 50 mL plastic bag (IV, IV infusion)
Alcohol, Ethyl (1, 2)
Oral: 95%, USP grade
Inj.: absolute, 1 mL ampul (IV)
Solution:
70% topical solution
Alendronate (as sodium salt)
Oral: 10 mg and 70 mg tablet
Alendronate + Cholecalciferol
(vitamin D3)
Oral: 70 mg (as sodium salt) + 5600 IU tablet
Alfuzosin (as hydrochloride)
Oral: 10 mg tablet
2
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
All‐in‐one Admixtures
Solution:
Volume: 400 – 2500 mL
Concentration:
Variable
Protein:
3-6 g/100 mL
Carbohydrate:
6-15 g/100 mL Lipid: 2-5 g/ 100mL
Calories:
variable
Electrolytes:
variable
Allopurinol
Oral: 100 mg and 300 mg tablet
Alprazolam (A1)
Oral: ⊗250 microgram, 500 microgram and 1 mg tablet
Aluminum Hydroxide +
Magnesium Hydroxide
Oral: 225 mg aluminum hydroxide + 200 mg magnesium
hydroxide per 5 mL suspension, 60 mL and 120
mL
200 mg aluminum hydroxide + 100 mg magnesium
hydroxide tablet
Amikacin (as sulfate)
Inj.: 50 mg/mL, 100 mg/mL, 125 mg/mL and 250 mg/mL,
2 mL ampul/vial (IM, IV)
100 mg, 250 mg, 500 mg and 1 g vial (IM, IV)
Amino Acid + carbohydrate +
multivitamins + electrolytes
Inj.: solution for IV injection/infusion set, 1000 mL
Amino Acid + glucose +
electrolytes + vitamin B1
Inj.: solution for peripheral venous infusion 500 mL and
1000 mL
Amino Acid Solutions for
Immunonutrition /
Immunoenhancement
Solution:
Volume - 50 mL and 100 mL
Protein - 20 g; L‐alanyl‐L‐ glutamine
Calories - 70 ‐ 90
Electrolytes - none
Amino Acid Solutions for Infants
Solution:
Volume - 100 mL
Concentration - 5 ‐ 10 %
Protein – 5 - 10 g including taurine
Calories - 20 ‐ 40 kcal
Electrolytes - none
3
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Amino Acid Solutions for Renal
Condition
Solution:
Volume - 250 - 500 mL
Concentration - 3.5 ‐ 7 %
Protein – 17.5 ‐ 35 g rich in essential amino acid
Calories - 50 ‐ 200 Kcal
Amino Acid Solutions for Hepatic
Failure
Solution:
Volume - 500 mL Concentration - 5 ‐ 10 %
Protein - 35‐50 g; rich in branched‐chain amino
acids
Calories - 50 ‐ 200
Electrolytes - variable
Amino Acids, Crystalline
Standard
Inj.: 3.5%, 500 mL bottle (IV infusion)
5%, 100 mL, 250 mL and 500 mL bottle (IV infusion)
6%, 100 mL and 250 mL bottle (IV infusion)
7%, 8.5%, 10%, and 11.4%, 100 mL, 500 mL and
1 L bottle (IV infusion)
8%, 500 mL bottle (IV infusion) (as branched chain)
9.12%, 20 mL ampul and 200 mL bottle (IV
infusion)
10%, 100 mL and 500 mL bottle (IV infusion)
Aminophylline (theophylline
ethylenediamine) (1)
Inj.: 25 mg/mL, 10 mL ampul (IV)
Amiodarone (as hydrochloride)
(2)
Oral: 200 mg tablet
Inj.: 50 mg/mL, 3 mL ampul (IV) (2)
Amlodipine
(as besilate/camsylate)
Oral: 5 mg and 10 mg tablet
Amoxicillin (as trihydrate)
Oral: 250 mg and 500 mg capsule
100 mg/mL granules/powder for drops
(suspension), 15 mL
250 mg/5 mL granules/powder for suspension,60
mL
Amoxicillin + Potassium
Clavulanate (see Co‐Amoxiclav)
Amphotericin B (Lipid Complex) (as cholesteryl complex, colloidal dispersion) (1) *Reserve Antimicrobial Inj.: 50 mg and 100 mg vial (IV infusion) Amphotericin B (Non‐Lipid Complex) (1) *Reserve Antimicrobial Inj.: 50 mg lyophilized powder, vial (IV infusion) Ampicillin (as sodium salt) Inj.: 250 mg, 500 mg and 1 g vial (IM, IV)
4
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Ampicillin + Sulbactam
Inj.: 500 mg ampicillin + 250 mg sulbactam (IM, IV) (as
sodium salt) per vial
1000 mg ampicillin + 500 mg sulbactam (IM, IV)
(as sodium salt) per vial
2000 mg ampicillin + 1000 mg sulbactam (IM, IV) (as
sodium salt) per vial
Anastrazole
Oral: 1 mg film coated tablet
Anti‐D Immunoglobulin (human
anti‐D immunoglobulin)
Inj.: 200 micrograms/mL, 1.5 mL ampul (IM)
Antilymphocyte Immunoglobulin
(ALG) (equine) (1, 2)
Inj.: 100 mg/5 mL vial (IV)
Antithymocyte Immunoglobulin
(ATG) (rabbit) (1, 2)
Inj.: 25 mg/5 mL vial (IV)
Anti‐rabies serum (equine)
Inj.: 200 IU/mL, 5 mL vial (IM)
400 IU/mL, 5 mL vial (IM)
Anti‐tetanus serum (equine)
Inj.: 4000 IU/mL, 2.5 mL vial (IM)
1500 IU/0.7 mL solution for injection, vial/ampul
(IM)
1500 IU/mL, 1 mL and 1.5 mL vial/ampul (IM)
Aripiprazole
Oral: 10 mg, 15 mg, 20 mg and 30 mg tablet
10 mg and 15 mg orally disintegrating tablet (ODT)
Inj.: 300 mg and 400 mg (200 mg/mL) lyophilized
powder for extended-release suspension for
injection in pre-filled dual chamber syringe
Artemether + Lumefantrin (B)
Oral: 20 mg artemether + 120 mg lumefantrin tablet
Artesunate
Inj: 60 mg vial injectable
Rectal: 50 mg suppository
Ascorbic Acid (vitamin C)
Oral: 100 mg and 500 mg tablet
100 mg/5 mL syrup, 60 mL and 120 mL
100 mg/mL drops, 15 mL and 30 mL
Inj.: 250 mg/mL, 2 mL ampul (IV) (1, 2)
Asparaginase (1, 2)
Inj.: lyophilized powder, 10,000 IU vial (IV)
Aspirin
Oral: 80 mg, 100 mg tablet, 300 mg tablet and 325mg
tablet
Atenolol
Oral: 50 mg and 100 mg tablet
Atorvastatin calcium
Oral: 10 mg, 20 mg, 40 mg and 80 mg tablet
Atracurium (as besilate)
Inj.: 10 mg/mL, 2.5 mL and 5 mL ampul (IV)
Atropine (as sulfate) (1, 2)
Oral: 600 micrograms (equiv. to 500 mcg atropine) tablet
Inj.: 500 micrograms/mL, 600 micrograms/mL and 1
mg/mL, 1 mL ampul (IM, IV, SC) Eye Drops
Solution:
5
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
1%, 5 mL and 10 mL bottle
Azathioprine (1, 2) (B)
Oral: 50 mg tablet
Azithromycin
Oral: 250 mg capsule (as base*/asdihydrate)
250 mg and 500 mg (B) tablet (as base*/as
dihydrate/as monohydrate)
200 mg/5 mL powder for suspension, 15 mL and 60
mL (as base*/as dihydrate/as monohydrate)
Inj.: 500 mg powder, vial (IV infusion) (as base*/as
dihydrate)
Aztreonam
*Reserve Antimicrobial
Inj.: 1 g powder for injection
B
Bacitracin + Neomycin +
Polymixin B
Ointment:
200 units bacitracin + 3 mg neomycin (as sulfate)
+ 4000 units polymyxin B (as sulfate)/g, 10 g tube
Baclofen
Oral: 10 mg tablet
Balanced Multiple Maintenance
Solution
Inj.: with 5% dextrose, 250 mL and 500 mL (infants)
and 1 L (children and adults) bottle/bag (IV
infusion)
Composition: Infants Children & Adults Dextrose 50 g/L 50 g/L Na+ 25-30 mmol/L 40-50 mmol/L K+ 20-25 mmol/L 13-30 mmol/L Mg++ 1.35-1.65 mmol/L 1.65 mmol/L Cl- 22 mmol/L 40 mmol/L Acetate 23 mmol/L 16 mmol/L Balanced Multiple Replacement Solution Inj.: 500 mL and 1 L bottle/bag (IV infusion)
Composition:
Na+ — 140-145 mmol/L
K+ — 4-5 mmol/L
Mg++ — 1-1.65 mmol/L
Cl‐ — 98-127 mmol/L
Acetate — 24-50 mmol/L
plus 5% dextrose (50g/L)
Balanced Multiple Replacement Solution w/ pH 7.4 Inj.: 500 mL and 1 L bottle/bag (IV infusion)
Composition:
Na+ — 140 mmol/L
6
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
K+ — 5 mmol/L
Mg++ — 3 mmol/L
Cl‐ — 98 mmol/L
Acetate — 50 mmol/L
Barium Sulfate
Oral: powder, USP grade suspended in water 340 g
and 454 g, pouch, LDPE bag
Basiliximab (1, 2)
Inj.: 20 mg vial (IV infusion)
BCG Vaccine
Inj.: freeze‐dried powder, 100 micrograms/0.1 mL, 1 mL,
1.5 mL and 2 mL vial (ID)
500 micrograms/mL vial + 1 mL diluent in ampul
(ID) 20 doses
Bedaquiline fumarate
Oral: 100 mg tablet (For use by the National Tuberculosis
Control Program (NTP) of the Department of
Health (DOH) only.)
Benzoyl Peroxide
Gel: 5%, 20 g tube
Benzyl Benzoate
Lotion: 25%, 60 mL and 120 mL bottle
Beractant
Inj.: 25 mg/mL suspension, 4 mL and 8 mL vial,
Intratracheal administration (restricted to
tertiary hospitals with adequately trained
neonatologist and facilities for neonatal intensive
care)
Betahistine (as hydrochloride/
dihydrochloride)
Oral: 8 mg, 16 mg and 24 mg tablet
Betamethasone
Cream or Ointment:
0.05%, 5 g and 10 g tube (as dipropionate)
0.1%, 5 g tube (as valerate)
Betaxolol (as hydrochloride)
Eye Drops Suspension:
0.25%, 5 mL bottle Eye Drops Solution:
0.5%, 5 mL and 10 mL bottle
Bicalutamide
Oral: 50 mg and 150 mg tablet/ film coated tablet
Biperiden
Oral: 2 mg tablet (as hydrochloride)
Inj.: 5 mg/mL, 1 mL ampul (IM, IV) (as lactate)
Biphasic Isophane Human
Insulin 70/30 (recombinant DNA)
Inj.: 70% isophane suspension + 30% soluble insulin in:
100 IU/mL, 5 mL and 10 mL vial (SC)
100 IU/mL, 3 mL disposable syringe (SC)
100 IU/mL, 3mL glass cartridge (SC)
Bisacodyl
Oral: 5 mg tablet
5 mg MR tablet
Rectal: 5 mg (children) and 10 mg (adult) suppository
Bisoprolol
Oral: 2.5 mg and 5 mg tablet (as fumarate)
Bleomycin (as sulfate) (1, 2)
Inj.: powder, 15 IU ampul/vial (IM, IV)
7
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Brimonidine (as tartrate)
Ophthalmic Solution:
0.15%, 5 mL bottle
Brinzolamide
Ophthalmic Suspension:
1%, 5 mL bottle
Bromazepam (A1)
Oral: ⊗1.5 mg tablet
Bromocriptine (as mesilate)
(1, 2)
Oral: 2.5 mg tablet
Budesonide
Inhalation:
DPI: 100 micrograms/dose x 200 doses with
appropriate accompanyingdispenser
200 micrograms/dose x 100 doses and 200
doses with appropriate accompanying
dispenser
MDI: 200 micrograms/dose x 120 actuations
Resp. Soln.: (for nebulization) 250 micrograms/mL,
2 mL (unit dose)
Budesonide + Formoterol
Inhalation:
DPI: 80 micrograms budesonide + 4.5 micrograms
formoterol (as fumarate dihydrate) x 60
doses with appropriate accompanying
dispenser
160 micrograms budesonide + 4.5 micrograms
formoterol (as fumarate dihydrate) x 60
doses with appropriate accompanying
dispenser
320 micrograms budesonide + 9 micrograms
formoterol (as fumarate) x 60 doses with
appropriate accompanying dispenser
MDI: 80 micrograms budesonide + 4.5 micrograms
formoterol (as fumarate dihydrate) x 120
doses with appropriate accompanying
dispenser
160 micrograms budesonide + 4.5 micrograms
formoterol (as fumarate dihydrate) x 120
doses with appropriate accompanying
dispenser
Bumetanide
Oral: 1 mg tablet
Inj.: 500 micrograms/mL, 4 mL ampul (IM, IV)
Bupivacaine (as hydrochloride)
(1)
Inj.: 0.5%, 5 mL, 10 mL and 20 mL vial
0.5%, 5 mL, 10 mL, 20 mL and 50 mL ampul/vial
(local infiltration)
0.5% 4 mL ampul (spinal) with 8% dextrose
8
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
0.5% (isobaric), 5 mL ampul (spinal)
Butamirate (as citrate) (2)
Oral: 50 mg MR tablet
7.5 mg/5 mL syrup, 120 mL
Butorphanol (as tartrate) (A1)
Inj.: 2 mg/mL, 1 mL and 2 mL ampul/vial (IM, IV)
C
Calamine, Plain
Lotion: 8%, 60 mL and 120 mL bottle
Calcipotriol
Ointment:
50 microgram/g, 30 g tube or bottle
Calcipotriol + Betamethasone
Ointment:
50 microgram calcipotriol (as hydrate) + 500
microgram betamethasone (as dipropionate)/g,
30 g tube
Calcitriol (1, 2)
Oral: 0.25 microgram capsule
Calcium
Oral: tablet (equiv. to 500 mg elemental calcium) (as
lactate)
tablet/chewable tablet (equiv. to 500 mg and 600
mg elemental calcium) (as carbonate) powder,
USP grade (as chloride)
Inj.: 10% solution in 10 mL ampul (IV) (as gluconate)
Calcium Carbonate
Oral: tablet/chewable tablet (equiv. to 500 mg and600
mg elemental calcium)
Calcium Carbonate +
Cholecalciferol (vitamin D3)
Oral: Equiv. to 500 mg elemental Ca + 400 IU Vit. D3
Equiv. to 600 mg elemental Ca + 400 IU Vit. D3
Calcium Folinate (leucovorin
calcium) (1, 2)
Inj.: 10 mg/mL, 5 mL ampul/vial (IM, IV) 50 mg vial (IM,
IV)
Calcium Gluconate (1, 2)
Inj.: 10%, 10 mL ampul/vial (IV)
10%, 20 mL and 25 mL bottle (IV)
Calcium Sennosides (equivalent
to Standardized Senna
concentrate)
Oral: 8.77 mg and 17.54 mg (calculated as sennoside B)
tablet
Capecitabine (1, 2)
Oral: 150 mg and 500 mg tablet
Capreomycin
Inj.: 1 gram powder for injection (IV, IM)
Captopril
Oral: 25 mg and 50 mg tablet
Carbachol
Intraocular Solution:
0.01%, 1.5 mL vial
Carbamazepine
Oral: 200 mg tablet (B)
200 mg and 400 mg MR tablet 100 mg/5 mL syrup,
120 mL
Carbetocin
Inj.: 100 mcg/mL, 1 mL ampule/vial, solution for
Injection (IV)
9
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Carboplatin (1, 2)
Inj.: powder, 150 mg and 450 mg vial (IV)
10 mg/mL, 15 mL and 45 mL vial (IV)
Carboprost
Inj.: 125 mcg/0.5 mL solution for injection, 0.5 mL
ampul/vial
250 mcg/mL solution for injection, 1 mL
ampule/vial
Carboxymethylcellulose
(as sodium)
Eye Drops Solution:
0.5%, 0.4 mL and 15 mL bottle
Carvedilol
Oral: 6.25 mg tablet and 25 mg tablet
Castor Oil
Oral: USP grade
Cefalexin (as monohydrate)
Oral: 500 mg capsule
100 mg/mL, granules/powder for drops, 10 mL
125 mg/5 mL granules/powder for
syrup/suspension, 30 mL
250 mg/5 mL granules/powder for
syrup/suspension, 60 mL
Cefazolin (as sodium salt)
Inj.: 500 mg and 1 g vial (IM, IV)
Cefepime (as hydrochloride)
*Reserve Antimicrobial
Inj.: 500 mg, 1 g and 2 g vial (IM, IV)
Cefixime
Oral: 200 mg and 400 mg capsule (B)
20 mg/mL granules for drops (suspension), 10 mL
100 mg/5 mL granules for suspension, 60 mL
Cefotaxime (as sodium salt)
Inj.: 250 mg vial + 2 mL diluent (IM, IV) 500 mg vial + 2
mL diluent (IM, IV)
Cefoxitin
Inj.: 1 g vial (IM, IV) (as sodium salt)
1g (as sodium) powder for injection with 4%
Dextrose Solution for Injection (IV Infusion)
Ceftaxidime (Ceftazidime)
Inj.: 250 mg, 500 mg and 1 g vial (IM, IV) (as
pentahydrate)
2 g vial (IV infusion) (as pentahydrate)
Ceftriaxone
(as disodium/sodium salt)
Inj.: 250 mg vial + 2 mL 1% solution of lidocaine (IM)
500 mg vial + 2 mL 1% solution of lidocaine (IM)
250 mg vial + 5 mL diluent (IV)
1 g vial + 3.5 mL 1% solution of lidocaine (IM)
1 g vial + 10 mL diluent (IV)
Cefuroxime
Oral: 500 mg tablet (as axetil)
125 mg/5 mL granules for suspension, 70 mL (as
axetil)
250 mg/5 mL granules for suspension, 50 mL
content in 120 mL bottle
Inj.: 250 mg and 750 mg vial (IM, IV)
1.5 g vial (IV infusion) (as sodium salt)
10
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Celecoxib
Oral: 100 mg, 200 mg and 400 mg capsule
Cetirizine
(as dihydrochloride)
Oral: 10 mg tablet
2.5 mg/mL syrup (oral drops), 10 mL
10 mg/mL drops, 10 mL
1 mg/mL solution, 30 mL and 60 mL
5 mg/5 mL syrup, 30 mL
Chlorambucil (1, 2)
Oral: 2 mg tablet
Chloramphenicol
Oral: 500 mg capsule
125 mg/5 mL suspension, 60 mL (as palmitate)
Inj.: 1 g vial (IV; IM if recommended by manufacturer)
(as sodium succinate)
Chlorhexidine
Solution:
0.12% and 4%, 50 mL, 120 mL, 380 mL, 500 mL,
4 L and 5 L (as gluconate)
Chloroquine (as phosphate or
diphosphate)
Oral: 250 mg (150 mg base) tablet
Inj.: 50 mg/mL, 20 mL vial (IM, IV)
Chlorphenamine
(Chlopheniramine) (as maleate)
Oral: 4 mg tablet
2.5 mg/5 mL syrup, 60 mL
Inj.: 10 mg/mL, 1 mL ampul/vial (IM, IV)
Chlorpheniramine (see
Chlorphenamine)
Chlorpromazine (as
hydrochloride)
Oral: 100 mg and 200 mg tablet
Ciclosporin (1, 2)
Oral: 25 mg, 50 mg and 100 mg capsule (B)
100 mg/mL solution, 50 mL
Ophthalmic Emulsion:
0.05%, 0.4 mL bottle
Cilostazol
Oral: 50 mg and 100 mg tablet
50 mg (20% w/w), 0.25 g sachet powder for oral
use
100 mg (20% w/w), 0.5 g sachet powder for oral use
Cinnarizine
Oral: 25 mg tablet
Ciprofloxacin
Oral: 250 mg and 500 mg tablet (as hydrochloride)
Inj.: 2 mg/mL, 100 mL vial (IV infusion) (as lactate)
400 mg/200 mL (IV infusion)
Cisplatin (1, 2)
Inj.: 1 mg/mL, 10 mL and 50 mL vial (IV)
Clarithromycin
Oral: 250 mg and 500 mg base tablet
125 mg/5 mL and 250 mg/5 mL granules/powder
for suspension, 50 mL
Clindamycin
Oral: 150 mg and 300 mg capsule (as hydrochloride)
75 mg/5 mL granules for suspension, 60 mL (as
palmitate hydrochloride)
11
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Inj.: 150 mg/mL, 2 mL ampul/vial and 4 mL ampul (IM,
IV) (as phosphate)
Clobetasol (as propionate)
Cream or Ointment: 0.05%, 5 g and 15 g tube
Shampoo: 0.05%, 25 mL bottle
Clofazimine (B)
Oral: 50 mg and 100 mg capsule (available under DOH
program)
Clomifene (1, 2)
Oral: 50 mg tablet (as citrate)
Clonazepam (A1)
Oral: ⊗500 micrograms and 2 mg tablet
Clonidine
Oral: 75 micrograms and 150 micrograms tablet (as
hydrochloride)
Inj.: 150 micrograms/mL, 1 mL ampul (IV) (as
hydrochloride)
Clopidogrel
Oral: 75 mg tablet
Clotrimazole
Cream: 1% (10 mg/ g), 3 g, 10 g and 20 g aluminum
collapsible tube
2% (20 mg/ g), 30 g aluminum collapsible tube
Vaginal Cream:
1%, 10 g aluminum collapsible tube
Ear Solution:
1% otic solution
Cloxacillin (as sodium salt)
Oral: 500 mg capsule
250mg/ 5mL powder for oral solution, 60 mL
Clozapine (1, 2)
Oral: 25 mg and 100 mg tablet (requires hematologic
monitoring)
Co-Amoxiclav (amoxicillin +
potassium clavulanate)
Oral: 500 mg amoxicillin (as trihydrate) + 125 mg
potassium clavulanate per tablet
875 mg amoxicillin (as trihydrate) + 125 mg
potassium clavulanate per tablet
200 mg amoxicillin (as trihydrate) + 28.5 mg
potassium clavulanate per 5 mL
granules/powder for suspension, 70 mL
400 mg amoxicillin (as trihydrate) + 57 mg
potassium clavulanate per 5 mL
granules/powder for suspension, 70 mL
600 mg amoxicillin (as trihydrate) + 42.9 mg
potassium clavulanate per 5 mL
granules/powder for suspension
Cobra Antivenin
Inj.: 800 MU/ 4.8 mL, 1 mL ampul (for IV infusion)
800 IU/mL, 5 mL ampul (IV infusion) (1, 2)
Codeine (A1)
Oral: 30 mg MR capsule (as phosphate)
12
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
10 mg/5 mL, 60 mL suspension
Colchicine
Oral: 500 microgram tablet
Colistin
*Reserve Antimicrobial
Inj.: 2,000,000 IU lyophilized powder for injection (IV
infusion)
Combined Glucose-Amino Acid
Solutions
Volume — 100 mL and 500 mL
Concentration — variable
Glucose (Sorbitol) — 25 ‐ 50 g
Protein — 20 ‐ 30 g
Calories — 300 ‐ 450 Kcal
Electrolytes — variable
Conjugated Estrogen
Oral: 625 micrograms and 1.25 mg tablet
Cotrimoxazole
(sulfamethoxazole +
trimethoprim)
Oral: 400 mg sulfamethoxazole + 80 mg trimethoprim
tablet/capsule (B)
800 mg sulfamethoxazole + 160 mg trimethoprim
tablet (B)
200 mg sulfamethoxazole + 40 mg trimethoprim/ 5
mL suspension, 70mL and 120mL
400 mg sulfamethoxazole + 80 mg trimethoprim
per 5 mL suspension, 60 mL
Inj.: 400 mg sulfamethoxazole + 80 mg trimethoprim, 5
mL ampul (IV infusion)
Crotamiton
Lotion: 10%, 60 mL bottle
Cyclophosphamide (1, 2)
Inj.: powder, 200 mg, 500 mg and 1 g vial (IV)
Cycloserine
Oral: 250 mg capsule
Cyproterone (as acetate) (1, 2)
Oral: 50 mg tablet
Cytarabine (1, 2)
Inj.: 20 mg/mL, 5 mL ampul (IM, SC, intrathecal)
100 mg/mL solution for injection, 1 mL, 5mL and
10 mL
D
Dacarbazine (1, 2)
Inj.: powder, 100 mg and 200 mg vial (IV, IV infusion)
Daclatasvir
Oral: 60 mg tablet
Dactinomycin (1, 2)
Inj.: powder, 500 micrograms vial (IV)
Danazol (1)
Oral: 200 mg capsule
Dantrolene (as sodium salt)
Oral: 25 mg and 50 mg capsule (1)
Inj.: 20 mg (with mannitol 3 g)/vial (for reconstitution
with 60 mL sterile water for injection) (IV) (1, 2)
Dapsone (B)
Oral: 100 mg tablet
Deferiprone (1, 2)
Oral: 500 mg tablet
Deferasirox
Oral: 125 mg and 250 mg dispersible tablets
Deferoxamine (as mesilate)
Inj.: powder, 500 mg vial (IM, IV infusion, SC)
13
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
(1, 2)
Delamanid
Oral: 50 mg film coated tablet (For use by the National
Tuberculosis Control Program (NTP) of the
Department of Health (DOH) only.)
Desflurane (1)
Inhalation:
240 mL bottle
Desmopressin (as acetate)
Oral: 100 micrograms and 200 micrograms tablet
Inj.: 15 micrograms/mL, 1 mL ampul (IM, SC) (as
acetate)
Dexamethasone
Oral: 500 micrograms, 750 micrograms, 3 mg and 4 mg
tablet
Inj.: 4 mg/mL, 1 mL and 2 mL ampul/vial (IM, IV) (as
sodium phosphate)
5 mg/mL, 1 mL ampul (IM, IV) (as sodium
phosphate)
Eye Drops Suspension:
0.1%, 5 mL bottle
Dextran, High Molecular Weight
(Dextran 70)
Inj.: 6% dextran 70 in 0.9% sodium chloride, 500 mL
bottle (IV infusion)
6% dextran 70 in 5% dextrose, 500 mL bottle (IV
infusion)
Dextromethorphan
(as hydrobromide) (2)
Oral: 10 mg tablet
5% Dextrose in 0.3% Sodium
Chloride
Inj.: 250 mL, 500 mL and 1 L bottle/bag (IV infusion)
Composition:
Dextrose — 50 g/L
Na+ — 51 mmol/L
Cl‐ — 51 mmol/L
5% Dextrose in 0.45% Sodium Chloride Inj.: 250 mL, 500 mL and 1 L bottle/bag (IV infusion)
Composition:
Dextrose — 50 g/L
Na+ — 77 mmol/L
Cl‐ — 77 mmol/L
5% Dextrose in 0.9% Sodium Chloride Inj.: 250 mL, 500 mL and 1 L bottle/bag (IV infusion)
Composition:
Dextrose — 50 g/L
Na+ — 154 mmol/L
Cl‐ — 154 mmol/L
14
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
5% Dextrose in Lactated Ringers
Inj.:
250 mL, 500 mL and 1 L bottle/bag (IV infusion)
Composition:
Dextrose — 50 g/L
Na+ — 130 mmol/L
K+ — 4 mmol/L
Ca++ — 1.22 – 1.5 mmol/L
Cl‐ — 109 mmol/L
Lactate — 28 mmol/L
5% Dextrose in Water
Inj.: 250 mL, 500 mL and 1 L bottle/bag (IV infusion
and as vehicle for IV medications)
10% Dextrose in Water
Inj.: 250 mL, 500 mL and 1 L bottle/bag (IV infusion)
3 mL ampul (as solvent)
Diazepam (1, A1)
Oral: ⊗5 mg tablet
Inj.: 5 mg/mL, 2 mL ampul (IM, IV)
Diclofenac
Oral: 25 mg and 50 mg tablet/capsule (as sodium or
potassium salt)
50 mg enteric coated tablet or MR tablet (as
sodium salt)
100 mg MR tablet/capsule (as sodium or potassium
salt)
Inj.: 25 mg/mL, 3 mL ampul (IM, IV) (as sodiumsalt)
Dicycloverine (Dicyclomine)
(as hydrochloride)
Oral: 10 mg tablet
10 mg/5 mL syrup, 60 mL
Diethylcarbamazine
Oral: 50 mg and 100 mg tablet (available under DOH
program)
Digoxin (2)
Oral: 250 micrograms tablet
50 micrograms/mL elixir, 60 mL
Inj.: 250 micrograms/mL, 2 mL ampul (IM, IV)
Diloxanide (as furoate)
Oral: 500 mg tablet (B)
125 mg/5 mL syrup/suspension, 30 mL and 60 mL
Diltiazem (as hydrochloride)
Oral: 60 mg tablet
60 mg, 120 mg, 180 mg and 240 mg MR capsule (as
hydrochloride)
120 mg and 180 mg MR tablet (as hydrochloride)
Dimeglumine Gadopentetate
Inj.: 469 mg/mL aqueous solution, 5 mL, 10 mL and 20
mL vial
Dimercaprol (1, 2)
Inj.: (in oil) 50 mg/mL, 2 mL ampul (IM)
Dimercaptopropane-sulphonate
(DMPS) (1, 2)
Inj.: 100 mg/mL, 1 mL ampul and 10 mL vial (IM)
Diphenhydramine (as
hydrochloride)
Oral: 25 mg and 50 mg capsule
12.5 mg/5 mL, 30 mL and 60 mL syrup
15
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Inj.: 50 mg/mL, 1 mL ampul (IM, IV)
Diphtheria Antitoxin
Inj.: 10,000 IU and 20,000 IU, 5 mL and 10 mL (IV)
Diphtheria, Tetanus, Pertussis,
Hepatitis B Recombinant and
Haemophilus Influenza Type B
(Hib) Combined Vaccine
Inj.: 0.5mL vial suspension for injection (IM)
Diphtheria-Tetanus Toxoids (DT)
Inj.: 30 IU diphtheria toxoid + 40 IU tetanus toxoid per
0.5 mL ampul (IM) (For less than 10 yrs. old)
Diphtheria-Tetanus Toxoids (Td)
Inj.: ≥ 2 IU diphtheria toxoid + ≥ 40 IU tetanus toxoid
per 0.5 mL ampul (IM) (For 7 yrs. old and above)
≥ 2 IU diphtheria toxoid + ≥ 40 IU tetanus toxoid per
0.5 mL (IM), multidose vial (10 doses per vial)
Diphtheria-Tetanus Toxoids and
Acellular Pertussis Vaccines
(DTaP)
Inj.: 0.5 mL pre‐filled syringe (IM)
Diphtheria-Tetanus Toxoids and
Pertussis Vaccine (DTP)
Inj.: 0.5 mL ampul (IM)
0.5 mL pre‐filled syringe (IM)
0.5 mL, 5 mL, 7.5 mL and 10 mL vial (IM)
Dipyridamole (2)
Oral: 25 mg tablet (preferably used in combination with
aspirin)
Divalproex Sodium
OR
Sodium Valproate + Valproic Acid Oral: 250 mg and 500 mg tablet 250 mg and 500 mg extended release (ER) tablet
Oral: 500 mg (333 mg sodium valproate + 145 mg
valproic acid) controlled releasetablet
Dobutamine (1, 2)
Inj.: 50 mg/mL, 5 mL ampul (concentrate) (IV
infusion) (as hydrochloride)
2 mg/mL, 250 mL D5W (pre‐mixed) (IV) (as
hydrochloride)
Docetaxel (1, 2)
Inj.: 10 mg/mL solution for infusion (IV), 2 mL and 8 mL
vial
20 mg/0.5 mL, 0.5 mL vial (IV infusion) (anhydrous)
40 mg/mL, 2 mL vial (IV infusion) (anhydrous)
20 mg/mL, 1mL concentrate for solution for IV
infusion (as trihydrate)
80 mg/4mL, 4 mL concentrate for solution for IV
infusion (as trihydrate)
Dolutegravir
Oral: Oral: 50 mg tablet
Domperidone
Oral: 10 mg tablet
1 mg/mL suspension, 60 mL
Donepezil
Oral: 5 mg and 10 mg tablet/ orodispersible tablet (ODT)
Dopamine (as hydrochloride) (1,
Inj.: 40 mg/mL, 5 mL vial/ampul (IV
16
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
2)
800 micrograms/mL, 250 mL D5W (pre‐mixed) (IV)
1.6 mg/mL, 250 mL D5W (pre‐mixed) (IV)
Dorzolamide
Eye Drops Solution:
2%, 5 mL vial (as hydrochloride)
Doxorubicin (as hydrochloride)
(1, 2)
Inj.: powder, 10 mg and 50 mg vial (IV)
2 mg/mL, 5 mL and 25 mL vial (IV)
Doxycycline
Oral: 100 mg capsule (as hyclate)
DTaP + Hib
Inj.: 0.5 mL pre‐filled syringe (IM)
DTP + Hepatitis B Vaccine
(recombinant)
Inj.: 0.5 mL vial (IM, SC)
DTP + Hib
Inj.: 0.5 mL DTP diluent in pre‐filled syringe + freeze‐
dried, 10 microgram Hib vial (IM, SC)
DTP + Inactivated Polio Vaccine
(IPV)
Inj.: 0.5 mL monodose vial (IM, SC)
0.5 mL pre‐filled syringe (IM, SC)
DTP + IPV + Hib
Inj.: 0.5 mL pre‐filled syringe (IM, SC)
Dydrogesterone
Oral: 10 mg tablet
E
Efavirenz
Oral: 50 mg, 100 mg, 200 mg and 600 mg tablet/capsule
Emtricitabine + Tenofovir
Disoproxil Fumarate
Oral: 200 mg FDC Emtricitabine + 300 mg Tenofovir
Disoproxil Fumarate (fixed-dose combination)
tablet
Enalapril (as maleate)
Oral: 5 mg and 20 mg tablet
Enalapril + Hydrochlorothiazide
Oral: 20 mg enalapril + 12.5 mg hydrochlorothiazide
tablet
Enoxaparin (as sodium salt) (1,
2)
Inj.: 100 mg/mL, 0.2 mL, 0.4 mL and 0.6 mL pre‐filled
syringe (SC)
Entecavir
Oral: 500 mcg and 1 mg tablet/ film-coated tablet
0.05 mg/mL oral solution
Enteral Nutrition - Adult Polymeric
Oral/ Tube Feed:
Calories — 100 ‐ 475 Kcal
Dilution — 1:1 ‐ 2:1
Carbohydrates — 13.8 ‐ 59 g
Protein — 3.8 ‐ 19.9 g
Fat — 3.4 ‐ 21.5 g
mOsm/kg — 270 ‐ 730
Sodium — 75 ‐ 402 mg
Potassium — 370 ‐ 580 mg
Calcium — 80 - 500 mg
Magnesium — 25 ‐ 500 mg
Fiber — 0 ‐ 1.5 g
17
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Phosphorous — 47 ‐ 307 mg
Volume — 100 mL ‐ 1 L
Enteral Nutrition - Disease
Specific
Oral/ Tube Feed:
Calories — 100 ‐ 1000 Kcal
Dilution — 1:1 ‐ 2:1
Carbohydrates — 10.4 ‐ 156 g
Protein — 5.5 ‐ 88 g
Fat — 3.3 ‐ 108 g
mOsm/kg — 230 ‐ 635
Sodium — 80 ‐ 2400 mg
Potassium — 172 ‐ 5600 mg
Calcium — 80 - 500 mg
Magnesium — 25 ‐ 500 mg
Phosphorous — 50 ‐ 1789 mg
Volume — 50 mL ‐ 500 mL
50 g ‐ 500 g
Enteral Nutrition - Fiber
Containing
Oral/ Tube Feed:
Calories — 100 ‐ 1048 Kcal
Dilution — 1:1 – 2:1
Carbohydrates — 13.8 ‐ 148 g
Protein — 3.8 ‐ 40 g
Fat — 3.4 ‐ 34.7 g
mOsm/kg — 270 ‐ 375
Sodium — 46.5 ‐ 930 mg
Potassium — 78.5 ‐ 1570 mg
Phosphorous — 63 ‐ 720 mg
Fiber — 2.0 ‐ 10.6 g
Volume — 500 mL
100 g ‐ 400 g
Enteral Nutrition - Modular
Oral:
Calories — 9.5 ‐ 380 Kcal
Dilution — 0
Carbohydrates — 0.67 ‐ 94 g
Protein — 5 ‐ 23 g
Fat — 0.6 g
mOsm/kg — 900
Sodium — 15 ‐ 110 mg
Potassium — 10 ‐ 66 mg
Phosphorous — 5 ‐ 30 mg
Volume — 280 g ‐ 400 g
Enteral Nutrition - Pediatric Polymeric Oral:
18
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Calories — 445 ‐ 511 Kcal
Dilution — 1:1
Carbohydrates — 14.9 ‐ 62.2 g
Protein — 13.4 ‐ 54.3 g
Fat — 16.2 ‐ 26 g
mOsm/kg — 308 ‐ 345
Sodium — 120 ‐ 250 mg
Potassium — 400 ‐ 750 mg
Phosphorous — 150 ‐ 760 mg
Volume — 100 g
Enteral Nutrition - Semi-
Elemental
Oral:
Calories — 100 ‐ 1300 Kcal
Dilution — 1:1 ‐ 1.5:1
Carbohydrates — 13.8 ‐ 177.2 g
Protein — 3.0 ‐ 66.6 g
Fat — 3.9 ‐ 37.4 g
mOsm/kg — 375 ‐ 575
Sodium — 66 ‐ 1040 mg
Potassium — 135 ‐ 1730 mg
Phosphorous — 22 ‐ 867 mg
Volume — 100 mL ‐ 1 L
76 g ‐ 450 g
Ephedrine (A1)
Inj.: 30 mg/mL, 1 mL ampul solution for injection
50 mg/mL, 1 mL ampul (IM, IV) (as sulfate)
Eperisone hydrochloride
Oral: 50 mg tablet
Epinephrine (adrenaline) (1, 2)
Inj.: 1 mg/mL, 1 mL ampul (IV, IM, SC) (as hydrochloride)
0.3 mg auto-injector (IM-Preload), 0.3 mL
preloaded injection pen
Epirubicin (as hydrochloride)
(1, 2)
Inj.: powder, 10 mg and 50 mg vial (IV)
Epoetin Alfa (recombinant human
erythropoietin) (1, 2)
Inj.: 2000 IU/0.5 mL, pre‐filled syringe (IV, SC)
4000 IU/0.4 mL, pre‐filled syringe (IV, SC)
4000 IU/mL, 1 mL vial (IV, SC)
10,000 IU/mL, pre‐filled syringe (IV, SC)
Epoetin Beta (recombinant
erythropoietin) (1, 2)
Inj.: 2000 IU/0.3 mL, pre‐filled syringe with needle
(IV, SC)
5000 IU/0.3 mL, pre‐filled syringe with needle
(IV, SC)
10,000 IU/0.6 mL, pre‐filled syringe (IV, SC)
Ergotamine (1, 2, A2)
Oral: 1 mg tablet (as tartrate)
Ertapenem (as sodium salt)
*Reserve Antimicrobial
Inj.: 1 g powder, vial (IM/IV)
19
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Erythromycin
Oral: 500 mg tablet (as stearate) (B)
200 mg/5 mL granules/powder for suspension,
60 mL (as ethyl succinate)
400 mg/5 mL granules/powder for suspension,
50 mL and 60 mL (as ethyl succinate)
Eye Ointment:
0.5%, 3.5 g and 5 g tube
Escitalopram (as oxalate)
Oral: 10 mg tablet
Esmolol (as hydrochloride) (1, 2)
Inj.: 10 mg/mL, 10 mL vial (IV)
100 mg/mL, 10 mL vial (IV)
Ethambutol (as hydrochloride)
Oral: 100 mg tablet (pediatric)
200 mg and 400 mg tablet
Ethinylestradiol + Desogestrel
Oral: 30 micrograms ethinylestradiol + 150 microgram
desogestrel per tablet
Ethinylestradiol +
Levonorgestrel
Oral: 30 micrograms ethinylestradiol + 150 microgram
levonorgestrel per tablet
Ethinylestradiol +
Norethisterone
Oral: 35 micrograms ethinylestradiol + 400 microgram
norethisterone acetate per tablet
Ethinylestradiol + Norgestrel
Oral: 30 micrograms ethinylestradiol + 300 microgram
norgestrel per tablet
Etonogestrel
68 mg subdermal implant
Etoposide (1, 2)
Inj.: 20 mg/mL, 5 mL ampul/vial (IV)
20 mg/mL, 10 mL vial (IV) powder 100 mg vial (IV)
Everolimus
Oral: 250 mcg and 500 mcg tablet
F
Factor IX Complex Concentrate
(coagulation factors II, VII, IX, X)
(1, 2)
Inj.: 100 IU/mL, 5 mL and 10 mL vial (IV) lyophilized
powder, 500 IU vial + diluent (IV)
Factor VIII Concentrate (1, 2)
Inj.: lyophilized powder, 100 IU/g vial + diluent (IV)
Famotidine
Oral: 20 mg tablet
Inj.: 20 mg powder/lyophilized powder for injection,
ampule/vial
Felodipine
Oral: 5 mg and 10 mg MR tablet
Fenofibrate (1)
Oral: 200 mg capsule
160 mg tablet
Fentanyl (as citrate) (A1)
Oral: 100 mcg, 200 mcg, 300 mcg and 400 mcg
sublingual (SL) tablets
Inj.: 50 micrograms/mL, 2 mL and 10 mL ampul(IV)
Ferrous Salt
Oral: tablet, (equiv. to 60 mg elementaliron)
solution, (equiv. to 15 mg elemental iron/0.6 mL)
drops, 15 mL and 30 mL
20
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
solution, (equiv. to 30 mg elemental iron/5 mL)
syrup, 60 mL
N.B.: The elemental iron content of a ferrous salt depends on the type of preparation as follows:
Ferrous fumarate – 33%
Ferrous gluconate – 12%
Ferrous lactate – 19%
Ferrous sulfate, hydrated – 20%
Ferrous sulfate, dessicated – 32%
Ferrous Salt + Folic Acid
Oral: 60 mg elemental iron + 400 microgram folic acid
per tablet/ capsule/film coated tablet
Filgrastim (G-CSF) (1, 2)
Inj.: 150 micrograms/0.6 mL, vial (IV, SC)
300 mcg/0.5 mL solution for injection in pre-filled
syringe (IV, SC)
300 micrograms/mL, vial (IV, SC) 300
micrograms/1.2 mL, vial (IV, SC)
Finasteride
Oral: 5 mg tablet
Fluconazole
Oral: 50 mg, 150 mg and 200 mg capsule
Inj.: 2 mg/mL, 100 mL vial (IV infusion)
Flucytosine (5-fluorocytosine)
(1)
Oral: 250 mg tablet
Flumazenil (1, 2)
Inj.: 100 micrograms/mL, 5 mL ampul (slow
IV, IV infusion)
Flunarizine (as hydrochloride)
Oral: 5 mg capsule
Fluocinonide
Cream or Ointment:
0.05%, 5 g and 15 g tube
Fluorescein (as sodium salt)
Inj.: 10% (100mg/mL), 5 mL ampul (IV)
Strips: 1 mg and 9 mg
Fluorouracil (1, 2)
Inj.: 50 mg/mL, 10 mL ampul/vial (IV, IV infusion)
Fluoxetine (1)
Oral: 20 mg dispersable tablet/capsule
Flupentixol (as decanoate) (1)
Inj.: 20 mg/mL, 1 mL ampul and 10 mL vial (IM)
Fluphenazine (as decanoate) (1)
Inj.: 25 mg/mL, 1 mL ampul and 10 mL vial (IM)
Flutamide (1, 2)
Oral: 250 mg tablet
Fluticasone (as propionate)
Nasal Aqueous Solution:
0.05%/dose x 120 doses Inhalation:
DPI: 50 micrograms/dose with appropriate
accompanying dispenser
250 micrograms/dose with appropriate
accompanying dispenser
21
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
MDI: 50 micrograms/dose x 60 doses and 120 doses
125 micrograms/dose x 60 doses and 120 doses
Resp. Soln.:
(for nebulization) 250 micrograms/mL, 2 mL
(unit dose)
Fluticasone (as propionate) +
Formoterol (as fumarate
dihydrate)
Inhalation:
MDI: 50 mcg/5 mcg x 120 actuations 125 mcg/5 mcg x
120 actuations
250 mcg/10 mcg x 120 actuations
Fluticasone (as propionate) +
Salmeterol (as xinafoate)
Inhalation:
DPI: 100 micrograms fluticasone + 50 micrograms
salmeterol x 28 doses and 60 doses with
appropriate accompanying dispenser
250 micrograms fluticasone + 50 micrograms
salmeterol x 28 doses and 60 doses with
appropriate accompanying dispenser
500 micrograms fluticasone + 50 micrograms
salmeterol x 28 doses and 60 doses with
appropriate accompanying dispenser
MDI: 50 micrograms fluticasone + 25 micrograms
salmeterol x 120 actuations (with dose counter*)
125 micrograms fluticasone + 25 micrograms
salmeterol x 120 actuations ()
250 micrograms fluticasone + 25 micrograms
salmeterol x 120 actuations ()
Folic Acid
Oral: 400 mcg, 800 mcg, 1 mg and 5 mg tablet /capsule
2.5mg/mL pediatric drops
5mg/5mL syrup
Fomepizole (4 – methylprazole)
(1, 2)
Inj.: 1 g/mL, 1.5 mL vial (IV)
Fondaparinux (as sodium salt)
Inj.: 2.5 mg/0.5 mL solution
Formoterol
Inhalation:
DPI: 12 mcg dry powder for inhalation
Fosfomycin
Oral: 3 g granules for solution
Furosemide
Oral: 20 mg and 40 mg tablet (B)
Inj.: 10 mg/mL, 2 mL ampul (IM, IV)
10 mg/mL, 25 mL ampul (IV infusion)
Fusidate Sodium / Fusidic Acid
Cream: 2%, 5g tube
Ointment:
2%, 15g tube
Eye Drops Suspension:
1%, 5 g tube (as sulfate)
22
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
G
Gabapentin
Oral: 100 mg and 300 mg capsule
Gadobutrol
Inj.: 1.0 mmol/mL solution for injection, 15 mL vial
1.0 mmol/mL solution for injection, 5 mL pre-filled
syringe
Gadoteric acid
Inj.: 0.5 mmol/mL solution for injection, 10 mL, 15 mL
and 20 mL vials
Ganciclovir
Eye Gel:
0.15%, 5 g tube
Inj.: 500 mg vial (IV infusion) (as sodium) (1, 2)
Gas Forming Agent
Oral:
Components per tablet:
Sodium bicarbonate — 470 mg
Glutamic acid — 70 mg
Tartaric acid — 420 mg
Silicon resin — 25 mg
Gemcitabine (as hydrochloride) (1, 2) Inj.: 200 mg and 1 g vial (IV infusion) Gentamicin (as sulfate) Inj.: 10 mg/mL, 2 mL ampul/vial (IM, IV) 40 mg/mL, 2 mL ampul/vial (IM, IV) Gliclazide Oral: 30 mg and 60 mg MR tablet 80 mg tablet Glucagon (as hydrochloride) (1, 2) Inj.: lyophilized powder, 1 mg + solvent (IM, IV, SC) Glucose (dextrose) Inj.: 50%, 50 mL vial (IV) 50%, 10 mL and 20 mL ampul (IV) 50%, 10 mL, 20 mL and 50 mL (85 Kcal) vial (IV) Glycerin (see Glycerol)
Glycerol (glycerin)
Oral: USP grade (liquid)
Rectal: 2 g and 2.5 g suppository
Glyceryl trinitrate (nitroglycerin)
Inj.: 1 mg/mL, 10 mL and 25 mL ampul (IV infusion)
(1, 2)
Goserelin (as acetate)
Inj.: 3.6 mg depot solution, pre‐filled syringe (SC)
10.8 mg depot solution, pre‐filled syringe (SC)
H
Haloperidol (1)
Oral: 2 mg, 5 mg, and 10 mg tablet (B)
Inj.: 5 mg/mL, 1 mL ampul (IM)
50 mg/mL, 1 mL (oily) ampul (IM) (as decanoate)
Halothane (1)
Inhalation: 250 mL bottle
Hemodialysis Solution
-
Acid Concentrates
23
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Composition:
Concentrates (g/L) Glucose – 0 – 49.5 g
Sodium chloride – 216.19 g – 270.8 g
Potassium chloride – 5.25 g – 6.7 g
Calcium chloride – 6.47 g – 9.9 g
Magnesium chloride – 3.58 g – 4.75 g
Glacial Acetic Acid – 8.1 g – 8.46 g
Purified Water - 1000 mL
-
Sodium bicarbonate 650 g powder
Hemophilus Influenzae type B
Conjugated Vaccine (Hib)
Inj.: 10 micrograms/0.5 mL, 1 dose vial + 0.5 mL diluent
with tetanus protein (IM)
10 micrograms/0.5 mL vial + 0.9% sodium chloride
with diphtheria CRM 197 protein (IM)
0.5 mL vial with meningococcal protein (IM)
Heparin (unfractionated)
(as sodium salt) (1, 2)
Inj.: 1000 IU/mL and 5000 IU/mL, 5 mL vial
(IV infusion, SC) (bovine origin)
Hepatitis A Inactivated Vaccine
Inj.: viral antigen not less than 720 EU in 0.5 mL
monodose vial (IM) (junior)
viral antigen not less than 1440 EU in 1.0 mL
monodose vial (IM) (adult)
80 units/0.5 mL (GBM strain) pre‐filled syringe
single dose (IM) (pediatric)
160 units/0.5 mL (GBM strain) pre‐filled syringe
single dose (IM) (adult)
Hepatitis B Immunoglobulin
(human)
Inj.: 0.5 mL, 1 mL and 2 mL vial (IM)
Hepatitis B Vaccine (recombinant
DNA)
Inj.: 10 micrograms/0.5 mL monodose vial (IM)
(pediatric)
10 micrograms/0.5 mL, 5 mL (10 dose) vial (IM)
20 micrograms/mL monodose vial (IM) adult (For
more than 10 years old)
20 micrograms/mL, 10 mL vial (10 doses/vial) adult
N.B.: Formulations of different manufacturers are
of equal or similar immunogenicity. Follow
strictly the recommended dose of each
manufacturer.
Human Papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine Inj.: 0.5 mL suspension, glass pre‐filled syringe (IM) 0.5 mL glass vial Human Papillomavirus vaccine types 16 and 18 (Recombinant, Inj.: 0.5 mL suspension in pre-filled syringe (type I
24
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
AS04 Adjuvanted)
glass)
with a plunger stopper (rubber butyl) with
sterile needle
0.5 mL in 3 mL monodose type 1 glass vial 1 mL in 3
mL glass vial
Human Recombinant Tissue
Type Plasminogen Activator
(Alteplase) (1)
Inj.: 50 mg powder for I.V. infusion
Hydralazine (as hydrochloride)
Oral: 25 mg and 50 mg tablet
Inj.: 20 mg/mL, 1 mL ampul (IM, IV)
Hydrochlorothiazide
Oral: 12.5 mg and 25 mg tablet
Hydrocortisone
Oral: 5 mg and 20 mg tablet
Inj.: 50 mg/mL, 2 mL vial (IM, IV) (as sodium succinate)
125 mg/mL, 2 mL vial (IV) (as sodium succinate)
powder, 100 mg and 250 mg vial (IV) (as sodium
succinate)
Cream or Ointment:
1%, 5 g and 10 g tube (1)
Lotion: 1% and 2.5%, 25 mL bottle (1)
Hydrogen Peroxide
Solution:
3%, 60 mL and 120 mL bottle
Hydroxychloroquine (as sulfate)
Oral: 200 mg tablet
Hydroxyethyl Starch
Inj.: 6% solution, 250 mL and 500 mL bottle (IV infusion)
Hydroxyurea (1, 2)
Oral: 500 mg capsule
Hydroxyzine (as dihydrochloride)
Oral: 25 mg tablet
2 mg/mL syrup, 100 mL
Hyoscine (as N-butyl bromide)
Oral: 10 mg tablet
Inj.: 5 mg/5 mL syrup, 60 mL
20 mg/mL, 1 mL ampul (IM, IV, SC)
Hypertonic lactate
Inj.: Solution for IV infusion
Each 250 mL contains:
Sodium Lactate Solution (50%) - 28.250 g (equal
with 14.125 Solution Lactate
Potassium Chloride - 0.075 g
Calcium Chloride 2H20 (100%) - 0.05 g Water for
Injection - q.s.
Composition:
Na+ - 504.15 mmol/L
K+ - 40.2 mmol/L
25
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Ca++ - 1.36 mmol/L
Cl- - 6.74 mmol/L
Lactate - 504.15 mmol/L
3% Hypertonic Saline Solution
(for diagnosis of pulmonary
tuberculosis)
Hypromellose
Eye Drops Solution:
5 mg/mL and 10 mg/mL, 10 mL and 15 mL bottle
Ophthalmic Solution:
0.3%, 10 mL bottle
I
Ibuprofen
Oral: 200 mg and 400 mg tablet
100 mg/5 mL, 60 mL syrup/suspension
200 mg/5 mL, 60 mL suspension
Idarubicin (as hydrochloride)
(1, 2)
Inj.: powder, 5 mg vial (IV)
Ifosfamide (1, 2)
Inj.: powder, 1 g and 2 g vial (IV infusion)
Imatinib (as mesilate) (1, 2)
Inj.: 100 mg and 400 mg tablet
Imiglucerase
Inj: 400 U powder for intravenous infusion, 20 mL vial
Imiquimod
Cream: 5%, aluminum foil sachet
Immunoglobulin Normal, Human
(IGIM)
Inj.: 160 mg/mL, 2 mL, 5 mL and 10 mL vial (IM)
Immunoglobulin Normal, Human
(IGIV) (1)
Inj.: 50 mg/mL, 10 mL, 20 mL, 50 mL, 100 mL and 200
mL vial (IV)
freeze‐dried powder, 1 g/bottle + 33 mL and 50 mL
reconstitution fluid (IV)
freeze‐dried powder, 2.5 g/bottle + 100 mL
reconstitution fluid (IV)
freeze‐dried powder, 5 g/bottle + 100 mL diluent
vial (IV)
freeze‐dried powder, 10 g/bottle + 260 mL diluent
vial (IV)
Inactivated Polio Vaccine (Types
1, 2, and 3), Salk
Inj: 0.5 mL per dose (suspension for injection) in 5 mL
multidose vial (IM, SC)
Inactivated Poliomyelitis Vaccine
(Types 1, 2 and 3)
Inj: 0.5 mL per dose, suspension for injection single-
dose/multidose vial (IM, SC)
Indacaterol (as maleate) +
glycopyrronium (as bromide)
Inhalation:
110 mcg + 50 mcg inhalation powder in hard
capsules
Indapamide
Oral: 1.5 mg MR tablet
Influenza Polyvalent Vaccine
Inj.: 0.5 mL vial + pre‐filled syringe diluent (IM)
26
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
0.5 mL suspension in a pre‐filled syringe or ampul
(IM) (adult)
15mcg/0.5mL, 5mL multidose glass vial
7.5 mcg/0.25 mL suspension for injection, 0.25 mL
single dose pre-filled glass syringe
N.B.: Strains as recommended by WHO
Insulin Glargine
Inj.: 100 IU/mL, 10 mL Vial
100 IU/mL, 3 mL Pre-filled Pen
Interferon Alfa 2B (human) (1,
2)
Inj.: 3 million IU and 5 million IU per mL vial + diluent
(IM, SC)
Intraocular Irrigating Solution
(balanced salt solution)
Solution:
15 mL, 250 mL and 500 mL bottle
Composition:
Sodium chloride — 0.64%
Potassium chloride — 0.075%
Calcium chloride — 0.048%
Magnesium chloride hexahydrate — 0.03%
Sodium acetate — 0.39%
Sodium citrate — 0.17%
Water for injection to make 100%
Iodine
Oral: aqueous iodine solution (Lugol'ssolution)
5% iodine, 10 % potassium iodide (total iodine ‐
130 mg/mL), 30 mL
Tincture:
1% and 2%
Solution:
2% and 5%
Iodixanol
Inj.: 652 mg/mL (equivalent to 320 mg iodine) solution
for injection, 50 mL and 100 mL vial
550 mg/mL (equivalent to 270 mg iodine) solution
for injection, 50 mL vial
Iodized Oil Fluid
Oral: 500 mg (equiv. to 200 mg elemental iodine) softgel
capsule (only for DOH program)
Iohexol
Inj.: (Intravascular and other parenteral routes as
appropriate)
300 mg iodine/mL, 50 mL and 100 mL vial
350 mg iodine/mL, 50 mL and 100 mL vial
Iopamidol
Inj.: (Intravascular and other parenteral routes as
appropriate)
612 mg/mL equiv. to 300 mg iodine, 50 mL and 100
27
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
mL vial
755 mg/mL equiv. to 370 mg iodine, 50 mL and 100
mL vial/bottle
Iopromide
Inj.: 300 mg/mL equiv. to 623 mg iodine, 50 mL and 100
mL vial
370 mg/mL equiv. to 769 mg iodine, 50 mL and
100 mL vial
Iothalamate
Inj.: 600 mg/mL, 30 mL, 50 mL and 100 mL vial
(usually IV) (as meglumine)
Ioversol
Inj.: 636 mg/mL equiv. to 300 mg/mL iodine, 50 mL and
100 mL vial
741 mg/mL equiv. to 350 mg/mL iodine, 50 mL
and 100 mL vial
Ipratropium (as bromide)
Inhalation:
MDI: 20 micrograms/dose x 200 doses
Resp. Soln.:
(for nebulization) 250 micrograms/mL, 2 mL (unit
dose)
Ipratropium (as bromide) +
Fenoterol (as hydrobromide)
Inhalation:
MDI: 20 micrograms ipratropium + 50 micrograms
fenoterol x 10 mL doses
Ipratropium + Salbutamol
Inhalation:
MDI: 20 micrograms ipratropium (as bromide) + 100
micrograms salbutamol x 200 doses x 10mL
Resp. Soln.: (for nebulization)
500 micrograms ipratropium (as bromide
anhydrous) + 2.5 mg salbutamol (as base) x
2.5 mL (unit dose)
Irbesartan
Oral: 150 mg and 300 mg tablet
Irbesartan +
Hydrochlorothiazide
Oral: 150 mg irbesartan + 12.5 mg hydrochlorothiazide
tablet
Irinotecan (as hydrochloride)
(1, 2)
Inj.: 40 mg/2 mL concentrate, vial (IV infusion)
100 mg/5 mL concentrate, vial (IV infusion)
Iron sucrose
Inj.: 20 mg/mL, 5 mL ampule
Isoflurane (1)
Inhalation:
100 mL and 250 mL bottle
Isoniazid
Oral: 300 mg and 400 mg tablet
200 mg/5 mL syrup, 120 mL
Isoniazid + Rifampicin (B)
Oral: 50 mg + 75 mg dispersible fixed dose combination
tablet (pediatric)
75 mg + 150 mg tablet
28
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Isoniazid + Rifampicin +
Ethambutol (B)
Oral: 75 mg + 150 mg + 275 mg tablet
Isoniazid + Rifampicin +
Pyrazinamide (B)
Oral: 50 mg + 75 mg + 150 mg dispersible fixed dose
combination tablet (pediatric)
Isoniazid + Rifampicin +
Pyrazinamide + Ethambutol (B)
Oral: 75 mg + 150 mg + 400 mg + 275 mg tablet
Isophane Insulin Human
(recombinant DNA)
Inj.: 100 IU/mL, 3 mL pre‐filled syringe (SC)
100 IU/mL, 5 mL and 10 mL vial (SC)
Isosorbide Dinitrate
Oral: 10 mg and 20 mg tablet 20 mg MR tablet/capsule
Sublingual:
5 mg tablet
Inj.: 1 mg/mL, 10 mL ampul (IV) (1)
Isosorbide-5-Mononitrate
Oral: 40 mg tablet
30 mg and 60 mg MR tablet/capsule
Isotonic electrolyte solution for IV
infusion
Each 1 liter (L) of the product contains:
Sodium chloride – 6.80 g
Potassium chloride – 0.30 g
Calcium chloride dihydrate – 0.37 g
Magnesium chloride hexahydrate – 0.20 g
Sodium acetate trihydrate – 3.27 g
Malic acid – 0.67 g
Isoxsuprine (as hydrochloride)
Oral: 10 mg and 40 mg tablet
Inj.: 5 mg/mL, 2 mL ampul (IM, IV infusion)
Itraconazole
Oral: 100 mg capsule
Ivermectin
Oral: 3 mg and 6 mg tablet
K
Kanamycin (as sulfate)
Inj.: 1 g vial (IM)
Ketamine (as hydrochloride)
(1, A1)
Inj.: ⊗50 mg/mL, 10 mL vial (IM, IV)
Ketoconazole
Cream: 2% (20 mg/ g), 3.5 g and 15 g aluminum collapsible
tube
Shampoo:
2% (20 mg/ g), 6 mL foil sachet, 10 mL, 60 mL
and 100 mL bottle
Ketoprofen
Oral: 100 mg tablet
Inj.: 50 mg/mL, 2 mL ampul (IM)
Ketorolac (as tromethamol)
Inj.: 30 mg/mL, 1 mL ampul (IM, IV)
L
Lactated Ringer's Solution
Inj.: 500 mL and 1 L bottle/bag (IV infusion)
29
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
(Ringer's Lactate)
Composition:
Na+ — 130 mmol/L
K+ — 4 mmol/L
Ca++ — 1.22 – 1.5 mmol/L
Cl‐ — 109 mmol/L
Lactate — 28 mmol/L
Lactulose
Oral: 3.3 g/5 mL (3.35 g/5 mL) syrup
Lagundi ● [Vitex negundo L.
( Fam. Verbenaceae)]
Oral: 300 mg and 600 mg tablet
300 mg/5 mL syrup, 60 mL and 120 mL bottle
600 mg/5 mL syrup, 60 mL and 120 mL bottle
Lamivudine
Oral: 100 mg and 150 mg tablet/film coated tablet
10mg/mL suspension, 240mL bottle
Lamivudine + Efavirenz +
Tenofovir
Oral: 300 mg + 600 mg + 300 mg tablet
Lamivudine +Tenofovir
Oral: 300 mg + 300 mg tablet
Lamivudine + Zidovudine
Oral: 150 mg + 300 mg tablet
Lamivudine + Zidovudine +
Nevirapine
Oral: 150 mg + 300 mg + 200 mg tablet
Lamotrigine
Oral: 50 mg and 100 mg tablet
Lansoprazole
Oral: 15 mg and 30 mg capsule
15 mg and 30 mg MR tablet
Latanoprost
Eye Drops Solution:
50 micrograms/mL, 2.5 mL bottle
Latanoporst + Timolol maleate
Opthalmic Solution:
50 mcg + 5 mg/mL, 5 mL bottle
Letrozole
Oral: 2.5 mg tablet/film-coated tablet
Leucovorin Calcium (see
Calcium Folinate) (1, 2)
Inj.: 10 mg/mL, 5 mL ampul/vial (IM, IV)
50 mg vial (IM, IV)
Leuproreline (as acetate) (1, 2)
Inj.: 3.75 mg/ 2 mL vial with syringe (IM, SC)
powder, 1.88 mg single dose with syringe (IM, SC)
powder, 3.75 mg single dose with syringe (IM, SC)
powder, 11.25 mg depot solution, vial with syringe
(IM, SC)
7.5 mg, 22.5 mg and 45 mg in pre-filled syringe
(SC)
Levetiracetam
Oral: 250 mg, 500 mg, 750 mg, and 1 g film coated tablet
Inj.: 500 mg/5 mL (100 mg/mL) concentrate solution for
IV infusion, 5 mL vial
Solution:
100 mg/mL oral solution, 100 mL and 300 mL
bottle
30
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Levobupivacaine
Inj.: 5 mg/mL solution for injection, 10 mL ampule
Levodopa + Carbidopa
Oral: 100 mg levodopa + 25 mg carbidopa per tablet
250 mg levodopa + 25 mg carbidopa per tablet
200 mg levodopa + 50 mg carbidopa extended
release tablet
Levofloxacin
Oral: 250 mg, 500 mg and 750 mg tablet
Inj.: 5 mg/mL solution for IV infusion, 100 mL and 150
mL
vial
Eye Drops:
5 mg/mL (0.5% w/v) ophthalmic solution
Levothyroxine
(as sodium/anhydrous sodium)
Oral: 50 mcg, 100 mcg and 150 mcg tablet
Lidocaine (as hydrochloride) (1,
2)
Inj.: 1%, 20 mL ampul
2% (20 mg/mL), 2 mL, 5 mL, 20 mL and 50 mL
ampul/vial (IM/IV)
2%, 5 mL and 50 mL vial (epidural, local infiltration)
2%, 1.8 mL carpule (with epinephrine) (local
infiltration) Spray: 10%, 50 mL
Linezolid
*Reserve Antimicrobial
Oral: 600 mg tablet/film-coated tablet
Inj.: 2 mg/mL (600 mg/300 mL), solution for infusion (IV)
Lipids
Inj.: 10%, 100 mL, 200 mL and 500 mL bottle (IV infusion)
20%, 100 mL, 250 mL and 500 mL bottle (IV
infusion)
Lithium Carbonate (1)
Oral: 450 mg MR tablet
Live Attenuated Bivalent Oral
Polio Vaccine (Type 1 and 3)
Oral: 2 mg vial (20 doses)
Live Attenuated Measles
Vaccine
Inj.: monodose vial + 0.5 mL diluent (SC)
multidose vial + 5 mL diluent (SC)
Live Attenuated Measles,
Mumps and Rubella (MMR)
Vaccine
Inj.: monodose vial + 0.5 mL diluent (SC) multidose vial
+
5 mL diluent (SC)
Live Attenuated Measles and
Rubella (MR) Vaccine
Inj.: multidose vial (10 doses/vial) + 5 mL diluent (SC),
with vaccine vial monitor (VVM)
Live Attenuated Mumps Vaccine
Inj.: monodose vial + 0.5 mL diluent (SC)
Live Attenuated Rubella Vaccine
Inj.: monodose vial + 0.5 mL diluent (SC)
multidose vial + 5 mL diluent (SC)
Live Attenuated Varicella Vaccine
Inj.: freeze‐dried powder, not less than 2000 PFU (OKA
strain varicella zoster virus)
monodose vial + diluent (0.5 mL water for injection)
ampul (SC only)
Loperamide (as hydrochloride)
Oral: 2 mg capsule
31
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
(N.B.: Not for infants and children less than 12
years old)
Lopinavir + Ritonavir
Oral: 200 mg + 50 mg tablet/capsule
40 mg + 10 mg oral pellets contained in capsule
Loratadine
Oral: 10 mg tablet/film coated tablet
5 mg/5 mL syrup, 30 mL
Losartan (as potassium salt)
Oral: 50 mg and 100 mg tablet
Losartan + Hydrochlorothiazide
Oral: 50 mg losartan + 12.5 mg hydrochlorothiazide
tablet
Lynestrenol
Oral: 500 mcg tablet
M
Magnesium Sulfate (as
heptahydrate) (1, 2)
Inj.: 250 mg/mL, 2 mL and 10 mL ampul (IM, IV)
250 mg/mL, 10 mL, 20 mL and 50 mL vial (IV)
500 mg/mL, 2 mL and 10 mL ampul (IM, IV)
Mannitol
Inj.: 20%, 250 mL and 500 mL bottle (IV)
Mebendazole
Oral: 100 mg tablet/capsule
500 mg tablet/chewable tablet
50 mg/mL suspension, 10 mL
100 mg/5 mL suspension, 30 mL and 60 mL
Mebeverine (as hydrochloride)
Oral: 100 mg tablet
Mecobalamin
Oral: 500 microgram tablet
Inj.: 500 micrograms/mL, 1 mL ampul (IM, IV)
Medroxyprogesterone (2)
Oral: 5 mg and 10 mg tablet (as acetate)
Inj.: 50 mg/mL, 3 mL vial + syringe (IM) (as acetate)
(N.B. Use one (1) inch long needle)
150 mg/mL, 1 mL vial (IM) (as enanthate or acetate)
Mefenamic Acid
Oral: 250 mg and 500 mg tablet/capsule
Mefloquine (as hydrochloride)
(B)
Oral: 250 mg tablet
Megestrol (as acetate) (1, 2)
Oral: 40 mg and 160 mg tablet
Melphalan (1, 2)
Oral: 2 mg tablet
Memantine
Oral: 5 mg and 10 mg film coated tablet
Meningococcal polysaccharide
(Neisseria meningitidis) vaccine
Inj.: lyophilized powder, 50 micrograms/ 0.5 mL dose
(Group A + C) multidose (10 doses) + 5 mL
diluent vial (IM, SC)
lyophilized powder, 50 micrograms/ 0.5 mL dose
(Group A + C) single dose + 0.5 mL
diluent syringe (IM, SC)
lyophilized powder, 50 micrograms/ 0.5 mL dose
(Serogroup A + Serogroup B + Serogroup W135
32
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
+ Serogroup Y) multidose (10 doses) + diluent
vial (IM, SC)
Mercaptopurine (1, 2, B)
Oral: 50 mg tablet
Meropenem (as trihydrate)
*Reserve Antimicrobial
Inj.: 500 mg and 1 g powder, vial (IV)
Mesalazine (1)
Oral: 500 mg enteric coated tablet
500 mg enteric MR tablet
Rectal: 250 mg suppository
Sachet: 1.5 g gastro-resistant prolonged release (PR)
granules
Mesna (sodium-2-
mercaptoethanesulphonate) (1,
2)
Inj.: 100 mg/mL, 4 mL ampul (IV)
Metformin (as hydrochloride)
Oral: 500 mg tablet/film coated tablet 850 mg tablet
Methimazole (thiamazole)
Oral: 5 mg and 10 mg tablet
Methotrexate (1)
Oral: 2.5 mg tablet (as base, sodium salt or disodiumsalt)
Inj.: 5 mg/mL, 3 mL vial (IM, IV) (as sodium salt)
25 mg/mL, 2 mL ampul/vial (IM, IV, Intrathecal) (as
base)
25 mg/mL, 2 mL and 20 mL vial (IM, IV, Intrathecal)
(as sodium salt, preservative-free)
100 mg/mL, 10 mL vial (as base)
100 mg/mL, 10 mL vial (IM, IV, Intrathecal) (as
sodium salt, preservative-free)
Methyldopa
Oral: 250 mg tablet
Methylene Blue (1, 2)
Oral: 1% solution
Inj.: 10 mg/mL, 1 mL and 10 mL ampul/vial
Methylergometrine
(methylergonovine) (as hydrogen
maleate or maleate) (A2)
Inj.: 200 micrograms/mL, 1 mL ampul (IM, IV)
Methylergonovine (see
Methylergometrine)
Methylphenidate (1, 2, A1)
Oral: 10 mg tablet
18 mg, 27 mg and 36 mg MR tablet 20 mg modified
release capsule
Methylprednisolone
Oral: 4 mg and 16 mg tablet
Inj.: powder, 125 mg/mL, 2 mL vial + diluent vial (IM, IV,
IV infusion) (as sodium succinate)
40 mg in single dose vial, solution for injection (IV,
IM) (as sodium succinate)
powder, 500 mg, 7.7 mL vial (IV) + diluent vial (IM,
IV, IV infusion) (as sodium succinate)
powder, 1 g/16 mL vial + diluent vial (IM, IV, IV
33
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
infusion) (as sodium succinate)
lyophilized powder, 125 mg vial (IM, IV) (as sodium
succinate)
lyophilized powder, 500 mg vial (IM, IV) (as sodium
succinate)
lyophilized powder, 1 g vial (IM, IV) (as sodium
succinate)
powder, 500 mg/8.0 mL vial + diluent vial (IM, IV, IV
infusion) (as sodium succinate)
Metoclopramide
Oral: 10 mg tablet (as hydrochloride)
5 mg/5 mL syrup, 60 mL (as base and as
hydrochloride)
Inj.: 5 mg/mL, 2 mL ampul (IM, IV) (as base and as
hydrochloride)
Metoprolol (as tartrate)
Oral: 50 mg and 100 mg tablet
Metronidazole
Oral: 250 mg and 500 mg tablet
125 mg base/5 mL (200 mg/5 mL (as benzoate))
suspension, 60 mL
Inj.: 5 mg/mL, 100 mL vial (IV infusion)
Micafungin
*Reserve Antimicrobial
Inj.: 50 mg lyophilized powder for infusion (IV)
Miconazole
Oral gel:
20 mg, 3.5 g aluminum tube
Topical Cream:
2% (20 mg/g), 5 g aluminum collapsible tube
Vaginal suppository:
1.2 g, casing strip x 1’s
Micronutrient Powder
Per 1 gram sachet:
Vitamin A - 400 ug RE
Vitamin C - 30 mg
Vitamin D - 5 ug
Vitamin E - 5 mg a-TE
Vitamin B1 - 0.5 mg
Vitamin B2 - 0.5 mg
Vitamin B6 - 0.5 mg
Vitamin B12 - 0.9 ug
Folic acid - 150 ug
Niacin - 6 mg
Iron - 10 mg
Zinc - 4.1 mg
Copper - 0.56 mg
Iodine - 90 ug S
34
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
elenium - 17 ug
Midazolam (A1)
Oral: ⊗15 mg tablet
Inj.: 1 mg/mL, 5 mL ampul/vial (IM, IV)
5 mg/mL, 1 mL, 2 mL, 3 mL, 5 mL and 10 mL ampul
(IM, IV)
Mitoxantrone (1, 2)
Inj.: 2 mg/mL solution, 5 mL and 10 mL
Modified Fluid Gelatin
(polymerisate of degraded
succinylated gelatin
Inj.: 3% and 4% solution, 500 mL bottle (IVinfusion)
Monobasic/Dibasic Sodium
Phosphate
Oral: 48 g/18 g per 100 mL solution, 45 mL bottle
Rectal: 19 g/7 g solution per 133 mL and 66 mL bottle
(enema)
Montelukast (as sodium salt) (1)
Oral: 4 mg granules, sachet
4 mg and 5 mg chewable tablet
10 mg tablet
Morphine (as sulfate) (A1)
Oral: 10 mg, 20 mg and 30 mg tablet/capsule
10 mg, 30 mg, and 60 mg MRtablet
Inj.: 10 mg/mL, 1 mL ampul (IM, IV, SC)
16 mg/mL, 1 mL ampul (IM, IV)
Moxifloxacin
Oral: 400 mg film coated tablet
Ophthalmic solution:
5 mg/mL (0.5% w/v) sterile ophthalmic solution, 5
mL bottle (as hydrochloride)
35
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Multivitamins
Oral:
Composition: Infants (per 1 mL drops) Children (per 5 mL syrup) Vitamin A 325 - 380 mcg 350 - 400 mcg Vitamin B1 0.2 – 0.4 mg 0.5 – 1.0 mg Vitamin B2 0.3 – 0.4 mg 0.7 – 0.9 mg Vitamin B6 0.3 – 0.6 mg 0.9 – 1.6 mg Vitamin B12 0.3 – 0.4 mcg 0.9 – 3.0 mcg Vitamin C 30 mg 35 - 55 mg Vitamin D 200 – 400 IU (5 – 10 mcg) 200 – 400 IU (5 – 10 mcg) Vitamin E 3 – 4 mg 5 – 7 mg Folic Acid 20 – 65 mcg 40 – 300 mcg Niacin 1 – 5 mg 5 – 18 mg
Adult (per tablet/capsule) Vitamin A 600 - 700 mcg or 2000 – 2500 IU Vitamin B1 1.3 – 1.7 mg Vitamin B2 0.7 – 1.3 mg Vitamin B6 1.6 – 2.0 mg Vitamin B12 2.0 – 6.0 mcg Vitamin C 60 – 80 mg Vitamin D 400 IU (10 mcg) Vitamin E 6 –10 mg (15 – 30 IU) Folic Acid 400 mcg Niacin 13 – 23 mg
Mupirocin
Cream: 2%, 5 g sachet and 15 g tube
Ointment:
2%, 5 g and 15 g tube
Mycophenolate Mofetil (1, 2)
Oral: 500 mg tablet
Mycophenolic Acid (as
Mycophenolate Sodium) (1, 2)
Oral: 360 mg tablet
N
N-acetyl Penicillamine (1, 2)
Oral: crystals, 25 g/bottle
Nalbuphine (as hydrochloride)
(A1)
Inj.: 10 mg/mL, 1 mL ampul (IM, IV, SC)
Nalidixic Acid
Oral: 500 mg tablet
36
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
250 mg/5 mL suspension, 60 mL
Naloxone (as hydrochloride)
(1, 2)
Inj.: 400 micrograms/mL, 1 mL ampul (IM, IV, SC)
Naltrexone (as hydrochloride)
Oral: 50 mg tablet
Naproxen (as sodium salt)
Oral: 250 mg base (275 mg) and 500 mg base (550mg)
tablet
Neomycin (as sulfate) +
Polymixin B (as sulfate) +
Fluocinolone Acetonide
Ear Drops Solution:
3.5 mg neomycin + 10,000 units
polymyxin B + 0.025% fluocinolone
acetonide/mL, 5
Neostigmine
Inj.: 500 mcg/mL, 10 mL vial
500 mcg/mL solution for injection (IM/IV/SC), 1 mL
ampule
Nepafenac
Eye Suspension:
1 mg/mL, 5 mL bottle
Nevirapine
Oral: 200 mg tablet (B)
50 mg dispersible tablet
50 mg/5 mL suspension, 240 mL
Nicardipine (as hydrochloride)
(1)
Inj.: 1 mg/mL, 2 mL and 10 mL ampul (IV)
Nicotine
Pastille:
1 mg and 2 mg
Gum: 1 mg and 2 mg
Nicotine transdermal
therapeutic system
Patch: 7 mg , 14 mg and 21 mg patch
Nifedipine
Oral: 10 mg capsule (B) (restricted use for acute
hypertensive emergencies in patients less
than 18 years old with extreme caution due to
rapid and prolonged fall in blood pressure)
30 mg MR tablet
Nimodipine
Oral: 30 mg tablet
Nitrofurantoin (B)
Oral: 50 mg and 100 mg capsule (asmacrocrystals)
Nitroglycerin (see Glyceryl
Trinitrate)
Inj.: 1 mg/mL, 10 mL and 25 mL ampul (IV infusion)
(1, 2)
Nitrous Oxide (1)
Inhalation: Anesthetic gas
Norepinephrine (as bitartrate) (1,
2)
Inj.: 1 mg/mL, 2 mL and 4 mL ampul (IV infusion)
1 mg/mL, 10 mL ampule (concentrate solution for
infusion)
2 mg /mL, 4 mL ampule (8 mg/4 mL) solution for
injection
Norethisterone (as acetate and
as base) (2)
Oral: 5 mg tablet
37
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Nystatin
Oral: 100,000 units/mL suspension, 30 mL
Vaginal:
100,000 units per tablet
O
Octreotide (as acetate) (1, 2)
Inj.: 100 micrograms/mL and 500 micrograms/mL, 1
mL ampul (IV infusion)
Ofloxacin
Oral: 200 mg tablet
Eye Drops Solution:
0.3%, 5 mL bottle
Ear Drops Solution:
0.3%, 5 mL bottle
Olanzapine (1, 2)
Oral: 5 mg and 10 mg tablet
10 mg orodispersible tablet (ODT)
Olodaterol (as hydrochloride)
Inhalation:
2.5 mcg/puff solution for inhalation, inhaler with 4
mL cartridge x 60 puffs (equiv. to 30
medicinal doses)
Omeprazole
Oral: 20 mg and 40 mg capsule
Inj.: powder, 40 mg vial + 10 mL solvent ampul/vial (IV)
Ondansetron (1, 2)
Oral: 8 mg tablet (as hydrochloridedihydrate)
Inj.: 2 mg/mL, 2 mL and 4 mL ampul (IM,IV)
Oral Rehydration Salts (ORS 75-
replacement)
Oral: Composition of reduced osmolarity ORS per liter of
water (WHO recommended):
Sodium chloride — 2.6 g
Trisodium citrate dihydrate — 2.9 g
Potassium chloride — 1.5 g
Glucose anhydrous — 13.5 g
Total Weight — 20.5 g
Reduced osmolarity ORS Equivalent in mmol/L:
Sodium — 75
Chloride — 65
Potassium — 20
Citrate — 10
Glucose anhydrous — 75
Total osmolarity — 245
N.B.: Reconstitute with clean potable water.
38
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Unused reconstituted solution shall be
discarded after 24 hours.
Oseltamivir (as phosphate)
Oral: 75 mg capsule
Oxacillin (as sodium salt)
Inj.: 250 mg and 500 mg vial (IM, IV)
Oxaliplatin (1, 2)
Inj.: 5 mg/mL concentrate solution, 10 mL and 20 mL
vial (IV infusion)
powder, 50 mg vial (IV infusion)
Oxcarbazepine
Oral: 300 mg and 600 mg tablet
60 mg/mL, 100 mL and 250 mL oral suspension
Oxycodone (as hydrochloride)
(A1)
Oral: 5 mg capsule
10 mg, 20 mg, 40 mg and 80 mg tablet/prolonged-
release or controlled release tablet
Inj: 10 mg/mL, 1 mL and 2 mL ampule for IV infusion
Oxycodone (as hydrochloride) +
Naloxone (as hydrochloride)
Oral: 5 mg + 2.5 mg, 10 mg + 5 mg, 20 mg + 10 mg,
40 mg + 20 mg tablet (prolonged-release)
Oxygen
Inhalation: (medicinal gas)
Oxymetazoline (as hydrochloride)
Nasal Drops Solution:
0.025%, 10 mL bottle Nasal Spray:
0.05%, 10 mL and 15 mL bottle
Oxytocin (synthetic) (2)
Inj.: 10 IU/mL, 1 mL ampul (IM, IV)
P
Paclitaxel (1, 2)
Inj.: 6 mg/mL, 5 mL, 16.7 mL, 17 mL, 25 mL and 43.4
mL vial (IV, IV infusion)
Paliperidone
Inj.: 50 mg/0.5 mL, 75 mg/0.75 mL, 100 mg/mL and
150 mg/1.5 mL prolonged release suspension
for injection (IM)
Pancuronium (as bromide) (1)
Inj.: 2 mg/mL, 2 mL ampul (IM, IV)
Pantoprazole
Oral: 20 mg and 40 mg tablet/enteric-coatedtablet
Para-amino salicylic acid
Sachet:
4 gram enteric coated delayed release granules in
sachet
Paracetamol
Oral: 300 mg and 500 mg tablet
100 mg/mL drops, 15 mL (alcohol‐free)
120 mg/5 mL (125 mg/5 mL) syrup/suspension, 30
mL, 60 mL and 120 mL (alcohol‐free)
250 mg/5 mL syrup/suspension, 30 mL, 60 mL and
120 mL (alcohol‐free)
Inj.: 150 mg/mL, 2mL ampule solution for injection
(IM/IV)
10 mg/mL, 50 mL and 100 mL vial solution for
39
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
infusion (IV)
Rectal: 125 mg and 250 mg suppository
Peginterferon Alfa 2A (1, 2)
Inj.: 135 micrograms/0.5 mL pre‐filled syringe (SC)
Penicillin G Benzathine
(benzathine benzylpenicillin)
Inj.: 1,200,000 units vial (MR) (IM)
Penicillin G Crystalline
(benyzylpenicillin) (as sodium
salt) (1, 2)
Inj.: 1,000,000 units vial (IM, IV)
5,000,000 units vial (IM, IV)
Peritoneal Dialysis Solution
Solution:
Sterile with 1.5%, 2.3 %, 2.5% and 4.25% dextrose, 2
L and 5 L bottle/bag
Content per liter:
Glucose Monohydrate – 16.5 g (equivalent to 15.0 g
glucose)
Fructose – up to 0.75 g
Sodium chloride – 5.786 g
Sodium (S) – lactate solution (equivalent to 3.925 g
sodium (S) – lactate) – 7.85 g
Calcium chloride dihydrate – 183.8 mg
Magnesium chloride hexahydrate – 101.7 mg
Permethrin
Lotion: 1%, 125 mL bottle
5%, 30 mL and 60 mL bottle Shampoo (Creme
Rinse):
1%, 30 mL and 60 mL bottle
Pethidine (meperidine) (as
hydrochloride) (A1)
Inj.: 50 mg/mL, 2 mL ampul (IM, IV, SC)
Petrolatum/ petroleum
Jelly: USP grade, 25 g, 100 g and 200 g jar
Phenobarbital (A1)
Oral: ⊗15 mg, 30 mg, 60 mg and 90 mg tablet
Inj.: 120 mg/mL (130 mg/mL), 1 mL ampul (IM, IV) (as
sodium salt)
Phenoxymethyl Penicillin
(penicillin V) (as potassium salt)
Oral: 250 mg and 500 mg tablet/capsule 250 mg/5 mL
granules/powder for syrup/suspension, 60 mL
Phenylephrine (as
hydrochloride)
Eye Drops Solution:
2.5%, 5 mL bottle
Phenytoin (as sodium salt)
Oral: 100 mg capsule (B)
30 mg/5 mL suspension, 120 mL
125 mg/ 5mL suspension, 120mL
Inj.: 50 mg/mL, 2 mL and 5 mL ampul (IV) (1)
Phospholipid fraction from
bovine lung
Inj.: 45 mg/mL (54 mg/1.2 mL) lyophilized powder for
suspension (intratracheal administration)
Physostigmine (as salicylate)
(1, 2)
Inj.: 1 mg/mL, 2 mL ampul (IM, IV)
40
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Phytomenadione (phytonadione,
vitamin K1)
Oral/Inj.:
2 mg/0.2 mL pediatric ampul (IM, IV, PO) (as mixed
micelle)
Inj.: 10 mg/mL, 1 mL ampul (IM, IV, SC) (as aqueous
colloidal solution with benzyl alcohol)
10 mg/mL, 1 mL ampul (IM, IV, SC) (as mixed
micelle)
Pilocarpine (as hydrochloride)
Eye Drops Solution:
1%, 10 mL and 15 mL bottle
2%, 10 mL and 15 mL bottle
Piperacillin + Tazobactam (as
sodium salt)
Inj.: 2 g piperacillin + 250 mg tazobactam per vial (IV
infusion)
4 g piperacillin + 500 mg tazobactam per vial
(IV infusion)
Pneumococcal Conjugate
Vaccine (PCV) Multi-dose vial
preparation indicated for the
following minimum serotypes: 1,
4, 5, 6B, 7F, 9V, 14, 18C, 19A,
19F and 23F
Inj.: 10-valent, 2 mL in a 3 mL multidose vial suspension
for IM injection
13 – valent, 0.5 mL single dose, 0.5 mL pre-filled
syringe, 2 mL in multidose vial suspension
for IM Injection
Pneumococcal Polyvalent
Vaccine
Inj.: 25 micrograms/0.5 mL (polysaccharide from each
capsular type) solution for injection, 0.5 mL
pre‐ filled syringe or single dose vial (IM, SC)
25 micrograms/0.5 mL solution for injection,
2.5 mL vial (IM, SC) (multidose)
Polymyxin B (as sulfate)
*Reserve Antimicrobial
Inj.: 500,000 Units powder for solution for injection
(Intrathecal/IM/IV), 5 mL vial
Poractant alfa
Inj.: 80mg/mL sterile suspension
(intratracheal/intrabronchial), 1.5 mL and 3
mL vial
Potassium (as citrate)
Oral: 1080 mg (10 mEq) tablet
1620 mg (15 mEq) extended release (ER) tablet)
Potassium Chloride
Oral: 600 mg tablet
750 mg durules (as chloride) equiv. to
Approximately 10 mEq potassium
Inj.: 1 mmol/mL syrup, 30 mL and and 60 mL(as
chloride)
2 mEq/mL, 2 mL and 5 mL ampul (IV infusion)
2 mEq/mL, 10 mL and 20 mL vial (IV infusion)
Potassium Phosphate
Inj.: 224 mg monobasic potassium phosphate equiv. to 3
mmol ph
41
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
osphorus and 4.4 mEq K/236 mg
dibasic potassium phosphate anhydrous per
mL in 5 mL vial (IV)
Povidone Iodine
Oral Antiseptic:
1%, 60 mL, 120 mL and 240 mL bottle Ointment:
10%, 5 g, 15 g and 30 g tube
Paint: 10%, 10 mL bottle
Solution:
10%, 15 mL, 30 mL, 60 mL, 120 mL, 1 L and 1
gallon bottle
Surgical Skin Cleanser:
7.5%, 60 mL, 120 mL, 480 mL, 1 L and 1 gallon bottle
Pralidoxime Chloride (1, 2)
Inj.: 50 mg/mL, 20 mL vial (IV)
Praziquantel (B)
Oral: 600 mg tablet (available under DOH program)
Prednisolone
Oral: 15 mg/5 mL syrup, 60 mL (as sodium phosphate)
Eye Drops Suspension:
0.5% and 1%, 5 mL bottle (as acetate)
Prednisone
Oral: 5 mg, 10 mg and 20 mg tablet
10 mg/5 mL suspension, 60 mL
Primaquine (as diphosphate)
Oral: 26.3 mg (15 mg base) tablet
Propofol (1)
Inj.: 10 mg/mL, 20 mL ampul (IV)
10 mg/mL, 50 mL pre‐filled syringe (IV)
10 mg/mL, 20 mL and 50 mL vial (IV)
Propranolol (as hydrochloride)
Oral: 10 mg and 40 mg tablet
Propylthiouracil
Oral: 50 mg tablet
Protamine Sulfate (1, 2)
Inj.: 10 mg/mL, 5 mL and 25 mL ampul (IV)
Prothionamide
Oral: 250 mg film coated tablet
Proxymetacaine (proparacaine)
(as hydrochloride)
Eye Drops Solution:
0.5%, 5 mL and 15 mL bottle
Pyrazinamide
Oral: 500 mg tablet
250 mg/5 mL and 500 mg/ 5mL suspension, 120 mL
Pyridostigmine (as bromide)
(1, 2)
Oral: 60 mg tablet
Pyridoxine (vitamin B6) (as
hydrochloride) (1, 2)
Oral: 100 mg tablet
Pyrimethamine (B)
Oral: 25 mg and 75 mg tablet
Q
Quetiapine (as fumarate)
Oral: 25 mg, 100 mg, 200 mg and 300 mg tablet
Quinine
Oral: 325 mg (300 mg base) tablet (as sulfate)
Inj.: 300 mg/mL, 1 mL ampul (IV) (as dihydrochloride)
250 mg/mL, 1 mL ampul (IV) (as dihydrochloride)
42
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
R
Rabeprazole sodium
Oral: 10 mg and 20 mg tablets
Rabies Immunoglobulin
(human)
Inj.: 150 IU/mL, 2 mL and 5 mL vial (IM)
150 IU/mL, 2mL, 5 mL and 10 mL ampul (IM)
Rabies vaccine, Chick Embryo
Cell (purified, inactivated)
Inj.: lyophilized powder, 2.5 IU/mL, 1 dose vial + 1 mL
diluent (ID, IM)
Rabies vaccine, Vero Cell
(purified)
Inj.: lyophilized powder, 2.5 IU/ 0.5 mL, vial + diluent (ID,
IM)
2.5 IU/mL suspension, 1 mL vial (IM)
Ranitidine (as hydrochloride)
Oral: 150 mg and 300 mg tablet
75 mg/5 mL syrup, 60 mL and 150 mL
Inj.: 25 mg/mL, 2 mL ampul/vial (IM, IV, IV infusion)
Regular, Insulin (recombinant
DNA human)
Inj.: 100 IU/mL, 3 mL pre‐filled syringe (SC, IV/IM)
100 IU/mL, 5 mL and 10 mL vial (SC, IV/IM)
Remifentanil
Inj.: 1 mg and 2 mg (in vial) lyophilized powder (IV
Infusion)
Retinol (vitamin A) (as palmitate)
(2)
Oral: 10,000 IU, 25,000 IU and 50,000 IU soft gel capsule
100,000 IU and 200,000 IU soft gel capsule with
nipple (only for DOH program) (B)
Ribavirin
Oral: 200 mg, 500 mg and 600 mg tablet
Rifabutin
Oral: 150 mg capsule (for HIV/AIDS patient on
concomitant protease inhibitor therapy, in
lieu of rifampicin)
Rifampicin
Oral: 300 mg, 450 mg and 600 mg tablet/capsule (B)
200 mg/5 mL suspension, 120 mL
Rifapentine
Oral: 150 mg film coated tablet
Rifaximin
Oral: 200 mg tablet
Rilpivirine (as hydrochloride)
Oral: 25 mg tablet
Risperidone
Oral: 1 mg, 2 mg, 3 mg and 4 mg tablet
1 mg and 2 mg orodispersible tablet 1 mg/mL oral
solution, 100 mL
Inj.: 25 mg and 37.5 mg MR powder for suspension, vial
+ 2 mL diluent in pre‐filled syringe (IM)
50 mg prolonged-release powder for suspension
for injection (IM) with 2 mL diluent (This
should not be administered to patients with
dementia- related psychoses because of
high risk of cardiovascular and infectious-
related deaths.)
Rituximab (1, 2)
Inj.: 10 mg/mL, 10 mL and 50 mL vial (IV)
43
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Rivastigmine (as hydrogen
tartrate)
Oral: 1.5 mg, 3 mg, and 6 mg capsule
Rocuronium (as bromide) (1)
Inj.: 10 mg/mL, 5 mL ampul/vial (IV)
Ropivacaine (as hydrochloride)
Inj.: 10 mg/mL, 10 mL ampul (IV)
Rosuvastatin (as calcium salt)
Oral: 10 mg and 20 mg tablet
S
Sacubitril/Valsartan
Oral: 50 mg, 100 mg and 200 mg tablet (Restricted for
patients with symptomatic heart failure with
reduced injection fraction (HF-rEF) and for
those who have been on stable doses of
angiotensin- converting enzyme (ACE)
inhibitors and/or angiotensin receptor
blockers (ARBs) but remain symptomatic.)
Salbutamol (as sulfate)
Oral: 2 mg/5 mL syrup, 60 mL
Inhalation:
Dry Powder Inhaler (DPI):
200 micrograms/dose with appropriate
accompanying dispenser
Metered Dose Inhaler (MDI):
100 micrograms/dose x 200 actuations
Breath Actuated MDI:
100 micrograms/dose x 200 actuations
Resp. Soln.:
(for nebulization)
1 mg/mL, 2.5 mL (unitdose)
2 mg/mL, 2.5 mL (unitdose)
Salicylic Acid
Solution:
5%, 30 mL and 60 mL bottle
Sambong [Blumea balsamifera
(L) DC (Fam. Compositae)] ●
Oral: 250 mg and 500 mg tablet
Selegiline (as hydrochloride)
Oral: 5 mg tablet
Selenium Sulfide
Lotion: 2.5%, 100 mL bottle
Sertraline (as hydrochloride)
Oral: 50 mg tablet
Sevelamer carbonate
Oral: 800 mg tablet
800 mg powder for suspension
Sevoflurane (1)
Inhalation:
250 mL bottle
Silver Sulfadiazine
Cream: 1%, 15 g and 25 g tube
500 g jar (micronized)
Simvastatin (1)
Oral: 20 mg and 40 mg tablet
Sirolimus (1, 2)
Oral: 0.5 mg and 1 mg tablet
44
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Sodium Bicarbonate
Oral: 325 mg and 650 mg tablet
Inj.: 1 mEq/mL, 10 mL vial (pediatric), 20 mL, 50 mL and
100 mL ampul/vial (adult) (IV infusion)
Sodium Calcium Edetate (1, 2)
Inj.: 200 mg/mL, 5 mL ampul (IM)
Sodium Chloride
Inj.: 2.5 mEq/mL, 20 mL and 50 mL vial
0.9% Sodium Chloride
Inj.: 2 mL, 2.5 mL, 5 mL, 10 mL and 20 mL ampul
50 mL, 100 mL, 200 mL, 500 mL and 1 L bottle/bag
(IV infusion)
Solution:
1 L bottle solution for irrigation
Composition:
Na+ — 154 mmol/L
Cl‐ — 154 mmol/L
Sodium Dichloroisocyanurate
(to be used for water purification)
Solution:
3.5 mg tablet (2 mg free available chlorine)
8.68 mg tablet (5 mg free available chlorine)
12.5 mg tablet (8 mg free available chlorine)
17 mg tablet (10 mg free available chlorine)
67 mg tablet (40 mg free available chlorine)
Sodium Hyaluronate
Ophthalmic Solution:
0.1% (1 mg/mL), 5 mL and 15 mL bottle
Sodium Hypochlorite
Solution: 1.25% available chlorine for water purification
Sodium Iodide 1311 (1, 2)
Oral: capsule with radioactivity range of 0.8 to 100 mCi
per capsule
capsule with radioactivity range of 1.0 to 250 mCi
per capsule
solution with radioactivity range of 3.5 to 150 mCi
per vial
Sodium Nitrite (1, 2)
Inj.: powder, USP grade
Sodium Nitroprusside (1, 2)
Inj.: 50 mg powder ampul (IV infusion)
Sodium Sulfate
Oral: powder, USP grade
Sodium Thiosulfate (1, 2)
Inj.: 250 mg/mL, 50 mL ampul (IV)
Solution:
2.5% and 5%
Sodium Valproate
Oral: 200 mg / 5 mL syrup, 100 mL bottle
Sodium Valproate + Valproic
Acid
Oral: 500 mg (333 mg sodium valproate + 145 mg
valproic acid) controlled release tablet
Sofosbuvir
Oral: 400 mg tablet
Sofosbuvir + ledipasvir
Oral: 400 mg + 90 mg tablet
Sofosbuvir + velpatasvir
Oral: 400 mg + 100 mg tablet
45
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Somatostatin (1, 2)
Inj.: 250 microgram and 3 mg ampul/vial (IV, IV infusion)
Soya bean oil + Medium chain
triglycerides + Olive oil +
Purified fish oil
Inj.: 200 mg/mL (20%) emulsion for IV infusion, 250 mL
Spectinomycin (2)
Inj.: 2 g vial (IM)
Spironolactone (K-sparer) (2, B)
Oral: 25 mg, 50 mg and 100 mg tablet
Standard Senna Concentrate
Oral: 187 mg and 374 mg tablet
Sterile Water for Injection
Inj.: 2 mL, 5 mL, 10 mL and 20 mL ampul
50 mL, 100 mL, 500 mL and 1 L bottle/bag
(no preservative)
Streptokinase (1, 2)
Inj.: powder, 1,500,000 IU vial (IV infusion)
Streptomycin (as sulfate)
Inj.: 1 g vial (IM)
Succimer (dimercapto succinic
acid, DMSA) (1, 2)
Oral: 100 mg and 200 mg capsule
Sucralfate
Oral: 1 g tablet
Sugammadex
Inj: 100 mg/mL solution for injection (IV), 2 mL vial
Sulfacetamide + Prednisolone
Eye Drops Suspension:
10% sulfacetamide + 0.25% prednisolone (as
acetate), 5 mL bottle
Sulfamethoxazole +
Trimethoprim (see Cotrimoxazole)
Sulfur
Cream: 2%, 10 g plastic tube
Ointment:
10%, 15 g and 30 g aluminum collapsible tube
Sumatriptan
Oral: 50 mg tablet
Suxamethonium
(succinylcholine) (as chloride)
(1)
Inj.: 20 mg/mL, 10 mL vial (IV)
T
Tacrolimus (1, 2)
Oral: 1 mg and 5 mg capsule
1 mg and 5 mg slow-release capsules
Tafluprost
Ophthalmic solution:
15 mcg/mL, 0.3 mL bottle single dose
ophthalmic solution
Tamoxifen (as citrate) (1, 2)
Oral: 10 mg and 20 mg tablet
Tamsulosin
Oral: 200 micrograms capsule (as hydrochloride)
200 mcg orally disintegrating tablet
400 mcg prolonged release film coated tablet
Tegafur + Uracil (1, 2)
Oral: 100 mg + 224 mg capsule
Telmisartan
Oral: 40 mg and 80 mg tablet
Telmisartan +
Hydrochlorothiazide
Oral: 40 mg + 12.5 mg tablet
46
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Tenofovir alafenamide fumarate
Oral: 25 mg tablet
Tenofovir disoproxil fumarate
Oral: 300 mg tablet
Tenofovir + Lamivudine +
Dolutegravir
Oral: 300 mg + 300 mg + 50 mg (fixed-dose combination)
tablet
Terazosin (as hydrochloride)
Oral: 1 mg, 2 mg and 5 mg tablet
Terbinafine
Oral: 250 mg tablet
Cream: 1%, 3 g, 5 g, 10 g and 15 g tube (as hydrochloride)
Terbutaline (as sulfate)
Oral: 5 mg tablet
1.5 mg/5 mL syrup, 60 mL
Inj.: 500 micrograms/mL, 1 mL ampul (IM, IV, SC)
Inhalation:
Resp. Soln.:
(for nebulization) 2.5 mg/mL, 2 mL unit dose
Testosterone (as undecanoate)
(1)
Inj.: 250 mg/mL solution for injection, 4 mL
Tetanus Immunoglobulin
(human)
Inj.: 1000 IU/mL, 1.5 mL vial (IM)
1500 IU/mL, 1 mL ampul (IM)
250 IU/mL, 1 mL, 2 mL and 4 mL ampul (IM)
250 IU/mL, 1 mL pre‐filled syringe (IM)
250 units/mL, 1 mL and 2 mL vial (IM)
Tetanus Toxoid
Inj.: 0.5 mL ampul (IM)
10 mL vial (IM)
Tetracaine
Inj.: 20 mg ampul (sterile powder) (spinal) (as
hydrochloride)
Tetracycline
Oral: 250 mg and 500 mg capsule
Theophylline (anhydrous)
Oral: 150 mg and 200 mg tablet (B)
200 mg MR tablet
25 mg/5 mL (26.7 mg/5 mL) syrup, 100 mL
Thiamine (Vitamin B1)
Oral: 100 mg and 300 mg tablet (as hydrochloride)
Inj.: 100 mg/mL, 1 mL ampul/vial (IV)
100 mg/mL, 10 mL vial (as hydrochloride) (IM, IV)
Thiopental Sodium (1, A1)
Inj.: 500 mg vial (IV)
1 g vial + 50 mL diluent (IV)
Timolol (as maleate)
Eye Drops Solution:
0.5%, 5 mL bottle
Tinzaparin (as sodium) (1, 2)
Inj.: 10,000 anti‐Xa IU/mL, 0.35 mL and 0.45 mL pre‐
filled syringe (SC)
10,000 anti‐Xa IU/mL, 2 mL vial (SC)
Tiotropium (as bromide)
Inhalation:
DPI: 18 micrograms/dose with appropriate
47
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
accompanying dispenser
Tobramycin
Eye Drops Solution:
0.3%, 5 mL bottle
Eye Ointment:
0.3%, 3.5 g tube
Tobramycin + Dexamethasone
Eye Drops Suspension:
0.3% + 0.1%, 5 mL bottle Eye Ointment:
0.3% + 0.1%, 3.5 g tube
Tocilizumab
Inj.: 80 mg/4 mL (20 mg/mL) Concentrate for Solution
for IV Infusion
200 mg/10 mL (20 mg/mL) Concentrate for Solution
for IV Infusion
400 mg/20 mL (20 mg/mL) Concentrate for
Solution for IV Infusion
Tolvaptan
Oral: 15 mg tablet
Topiramate
Oral: 25 mg, 50 mg and 100 mg tablet
Trace Elements
Inj.: contains Zn, Cu, Mn, Mg, Mb etc., 10 mL ampul (IV
nutrition)
Tramadol (as hydrochloride) (1)
Oral: 50 mg capsule
50 mg dispersible tablet
100 mg, 150 mg and 200 mg MR tablet
Inj.: 50 mg/mL, 1 mL and 2 mL ampul (IM, IV, SC)
Tranexamic Acid
Oral: 250 mg and 500 mg capsule 500 mg tablet
Inj.: 100 mg/mL, 2.5 mL and 5 mL ampul (IM, IV)
Trastuzumab (1, 2)
Inj.: 150 mg lyophilized powder (IV infusion)
600 mg/5 mL (120 mg/mL) solution for injection
(SC), 5 mL vial
Travoprost
Ophthalmic Solution:
0.004%, 2.5 mL bottle
Triclabendazole
Oral: 250 mg tablet
Trimetazidine (as hydrochloride)
Oral: 35 mg tablet
Tropicamide
Eye Drops Solution:
0.5%, 5 mL bottle
Tropicamide + phenylephrine
hydrochloride
Ophthalmic Solution:
5 mg + 5 mg/mL (eye drops) fixed dose
combination, 10 mL bottle
Tsaang Gubat ● [Carmona
retusa (Vahl) Masam (Fam.
Boraginaceae)]
Oral: 250 mg tablet
Tuberculin, Purified Protein
Derivative (PPD)
Inj.: 2 TU/0.1 mL solution, 1 mL and 5 mL vial (ID)
5 TU/0.1 mL, freeze‐dried powder, vial + 2 mL
diluent ampul (ID)
48
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Typhoid Vaccine
Oral: live attenuated S. typhi (not less than 109) viable
strain, enteric coated tablet(encapsulated)
Inj.: Vi‐capsular polysaccharide S. typhi 25 micrograms
in 0.5 mL pre‐filled syringe (IM)
U
Ursodeoxycholic Acid
Oral: 250 mg capsule
250 mg and 500 mg tablet
V
Valaciclovir (as hydrochloride)
Oral: 500 mg tablet
Valganciclovir
Oral: 450 mg tablet
Valproic Acid
Oral: 250 mg/5 mL syrup, 120 mL
Inj.: 500 mg/ 5mL IV infusion, 5 mL vial
Valsartan
Oral: 80 mg and 160 mg tablet/film coated tablet
Valsartan + Hydrochlorothiazide
Oral: 80 mg valsartan + 12.5 mg hydrochlorothiazide
tablet
Vancomycin (as hydrochloride)
*Reserve Antimicrobial
Inj.: 500 mg and 1 g vial (IV)
Varenicline
Oral: 0.5 mg and 1 mg tablet
Varicella Zoster Immunoglobulin
(VZIG)
Inj.: 125 units/1.25 mL vial (IM)
Vasopressin
Inj.: 20 IU/mL (IM, IV)
Vecuronium (as bromide) (1
Inj.: freeze‐dried powder, 4 mg/mL ampul + 1 mL
solvent (IV)
Verapamil (as hydrochloride)
Oral: 80 mg tablet (B)
240 mg MR tablet (for maintenance therapy)
Inj.: 2.5 mg/mL, 2 mL ampul (IV) (1, 2)
Vinblastine (as sulfate) (1, 2)
Inj.: powder, 10 mg vial for reconstitution (IV)
1 mg/mL, 10 mL vial (IV)
Vincristine (as sulfate) (1, 2)
Inj.: 1 mg/mL, 1 mL and 2 mL vial (IV)
Vitamin A (see Retinol)
Vitamin B1 B6 B12
Oral: 100 mg B1 + 5 mg B6 + 50 microgram B12 per
tablet/capsule
10 mg B1 + 5 mg B6 + 5 micrograms B12 per 0.6
mL drops, 15 mL
Inj.: 100 mg B1 + 100 mg B6 + 1 mg B12 per 3 mL ampul
(IV)
100 mg B1 + 100 mg B6 + 1 mg B12 per mL, 10 mL vial
(IV)
Vitamin B6 (see Pyridoxine)
Vitamin C (see Ascorbic Acid)
49
Active Ingredient
Route of Administration
Pharmaceutical Forms and Strengths
Vitamin Intravenous, Fat-Soluble
Inj.: contains vitamins A, D, E and K, 10 mL ampul (IV)
Vitamin Intravenous, Water-
Soluble
Vitamin K1 (see Phytomenadione)
Voriconazole (Inj. - *Reserve
Antimicrobial
Oral: 200 mg film-coated tablet
Inj.: 200mg lyophilized powder for solution for IV
infusion, 30mL Vial
W
Warfarin (as sodium salt) (1, 2)
Oral: 1 mg, 2.5 mg and 5 mg tablet
Y
Yellow Fever Vaccine
Inj.: 1000 DL 50 mouse min (attenuated) vial + 0.5 mL
solvent syringe (IM, SC) (For Bureau of
Quarantine Use Only)
Z
Zidovudine
Oral: 100 mg capsule
300mg tablet
50mg/5mL suspension, 240mL per bottle
Zidovudine + Lamivudine
Oral: 60 mg + 30 mg dispersible tablet
Zinc
Oral: chewable tablet, (equiv. to 10 mg elementalzinc)
(as gluconate)
tablet, (equiv. to 30 mg elemental zinc) (as
gluconate trihydrate)
88mg dispersible tablet (equivalent to 20mg zinc)
(as sulfate)
solution, (equiv. to 10 mg elemental zinc/mL) drops,
15 mL, (as sulfate monohydrate)
solution, (equiv. to 20 mg elemental zinc/5 mL)
syrup, 60 mL (as sulfate monohydrate)
70 mg/5 mL syrup (equivalent to 10 mg elemental
zinc), 60 mL and 120 mL (as gluconate)
Zoledronic Acid
Inj.: 4mg/5mL concentrated solution for IV Infusion
Zolmitriptan
Oral: 2.5 mg tablet
Zolpidem (A1)
Oral: ⊗10 mg tablet
50 FREQUENTLY ASKED QUESTIONS (FAQS) 1. What is the Philippine National Formulary (PNF)?
It contains the list of essential medicines that can be procured by the government. It also serves as the basis for Philhealth reimbursement for both public and private health facilities. 2. Who can apply medicines for inclusion in thePNF?
Only the following proponents can apply in the PNF: A. Pharmacy and Therapeutics Committee (PTC) of both public and private hospitals B. Professional medical societies recognized by the Philippine Medical Association (PMA) C. Patient groups D. National Health Programs (DOH Offices,Philhealth) E. Formulary Executive Council F. National Antibiotic Guidelines Committee 3. How to apply for inclusion of medicines in the PNF?
Applications for inclusion shall only be accepted within the month of January of eachyear.
The proponent shall completely accomplish the PNF form for inclusion, which shall be signed by the: A. PTC Chair for hospitals B. President for professional medical societies and patient organization C. Head of Office for National Health Programs
The form maybe downloaded from the Pharmaceutical Division website, www.pharmadiv.doh.gov.ph
Application may also be done online through: http://www.pnf.doh.gov.ph
The PNF secretariat shall check the completeness of submission before it will be presented to the Formulary Executive Council. Incomplete submissions will not be processed and will be returned to the proponent. 4. How to procure non-PNF medicines that are urgently needed?
This can be done through application for exemption from Executive Order No. 49 s. 1993 (Directing the Mandatory Use of the Philippine National Drug Formulary (PNDF) Volume I as the Basis for Procurement of Drug Products by the Government). The health facility shall completely accomplish the PNF form for exemption, which shall be signed by the: A. PTC Chair for hospitals B. Head of Office for National Health Programs
The form maybe downloaded from the Pharmaceutical Division website, www.pharmadiv.doh.gov.ph
The PNF secretariat shall check the completeness of submission before it will be presented to the Formulary Executive Council. Incomplete submissions will not be processed and will be returned to the proponent. 5. If an exemption is granted to a certain medicine, will this be applicable to all health facilities?
Only the requesting health facility shall be allowed to procure the exempted medicine. A certificate of exemption with a validity of one (1) year shall be issued totheproponent. 6. How do I get updates on the PNF?
Please visit the website of the Pharmaceutical Division, www.pharmadiv.doh.gov.ph, for the updated list of PNFmedicines.
You may also directly contact the PNF secretariat and look for Ms. Joyce Anne Ceria-Pereña or Ms. Johanna Mallari through thefollowing: A. Email address: pnf.doh@gmail.com / pndfs.secretariat@gmail.com B. Telephone number: 875-7734 ext. 253
RESERVE ANTIMICROBIALS
RESERVE ANTIBACTERIAL
Medicine Dosage Forms/Strengths Aztreonam 1 g Powder for injection Cefepime 500 mg (as Hydrochloride) Vial (IM, IV) 1 g (as Hydrochloride) Vial (IM, IV) 2 g (as Hydrochloride) Vial (IM, IV) Colistin 2,000,000 IU Lyophilized powder for injection (IV infusion) Ertapenem 1 g (as Sodium) Powder Vial (IM,IV) Linezolid 600 mg Tablet / Film-coated tablet 2 mg/mL (600 mg/300 mL) Solution for IV infusion (IV) Meropenem 500 mg (as Trihydrate) Powder Vial (IV) 1 g (as Trihydrate) Powder Vial (IV) Vancomycin 500 mg (as Hydrochloride) Vial (IV) 1 g (as Hydrochloride) Vial (IV)
RESERVE ANTIFUNGALS
Medicine Dosage Forms/Strengths Amphotericin B 50 mg (as Cholesteryl complex, colloidal dispersion) Vial (Lipid complex) 100 mg Vial (Lipid complex) 50 mg Lyophilized powder Vial (Non-lipid complex) Micafungin 50 mg Lyophilized powder for infusion (IV) Voriconazole 200 mg Film coated tablet 200 mg Lyophilized powder for solution for IV infusion, 30 mL Vial